Prevenir para una mejor salud – sustancias potencialmente cancerígenas
Hace unos días, la Organización Mundial de la Salud (OMS) publicó que las carnes procesadas causan cáncer, en la primera categoría. De la carne roja no hay certeza. Igual, varía según el método de preparación. En el Día Internacional de Lucha contra el Cáncer, es importante ver algunos puntos de la lista
La lista OMS de sustancias cancerígenas
En esta misma categoría, según publicó BBC Mundo, hay agentes conocidos como el tabaco los rayos ultravioleta, pero también algunas píldoras anticonceptivas o la práctica de determinados oficios, como el de ebanista o el de pintor. Recientemente el glifosato. Consumir carne procesada también genera un riesgo. Igualmente, depende mucho del caso y otros factores.
Así, la OMS ha armado cuatro grupos, a saber:
Grupo 1 carcinógeno para los seres humanos – 118 agentes conocidos
Grupo 2A Probablemente carcinógeno para los seres humanos – 75 agentes
Grupo 2B Posiblemente carcinógeno para los seres humanos – 288 agentes
Grupo 3 No clasificable en cuanto a carcinogenicidad en seres humanos 503
Grupo 4 probablemente no carcinógeno para los seres humanos – la carneeee
Algunas sustancias que pueden ser habituales y conviene evitar son:
-el cigarrillo
-lámparas y cambas solares
-arsénico en agua potable (recientemente, la corte habló del derecho humano al agua, que las autoridades deben cumplir)
-formaldehído (prohibido como alisador en la peluquería)
-humo del diesel…
y distintas sustancias que podés leer abajo según la clasificación.
Una lista dinámica
Explica el Dr. Carlos Damín, médico especialista en toxicología y jefe del área en el Hospital Juan A. Fernández que el mundo incorpora cientos de nuevas sustancias químicas cada año a la vida cotidiana. Sustancias que quizás sean prohibidas en un futuro no tan lejano. Mientras tanto “convivimos con al menos 118 que sabemos positivamente que producen daño a la salud, disminuyen la calidad de vida y pueden producir la muerte”.
Algunos cancerígenos como el arsénico, presentes en la naturaleza, en el agua de vastas zonas de nuestro planeta, afecta a todos los que no tienen otra alternativa para beber, aun sabiendo que les dañará, pero otros, como el tabaco, el alcohol, o los productos utilizados en el trabajo, necesitan más campañas de prevención, más educación y cuidado de la salud, más promoción de hábitos saludables.
La gran mayoría de los cánceres producidos por estas 118 sustancias conocidas son prevenibles y por eso debemos actuar en consecuencia, agrega Damin.
Prevenir en un trabajo
Hay actividades riesgosas que pueden requerir un mayor seguimiento. La superintendencia de riesgos de trabajo debe vigilar la aplicación de los standards de la ley 19587 de seguridad e higiene laboral para prevenir riesgos y enfermedades procesionales. Allí también se puede pedir una inspección para que controlen, por ejemplo, la ventilación adecuada yel aislamiento de los distintos agentes (radiaciones, químicos, etc).
Desde ya, la ART es responsable por accidentes o enfermedades profesionales. Los estudios de la OMS demostraron que los trabajadores de la industria del hierro tienen un riesgo más alto de desarrollar cáncer de pulmón, lo que amerita medidas de prevención y mayores controles.
Por otro lado, fomentar hábitos saludables que puedan no solo prevenir sino causar bienestar, también parte del concepto de salud, es un objetivo a implementarse.
Anexo con la lista completa de sustancias
|
CAS No.
|
Agent
|
Group
|
Volume
|
Year
|
Additional information
|
|---|---|---|---|---|---|
| 50-00-0 | Formaldehyde | 1 | Sup 7, 62, 88, 100F | 2012 | |
| 50-06-6 | Phenobarbital | 2B | Sup 7, 79 | 2001 | |
| 50-07-7 | Mitomycin C | 2B | 10, Sup 7 | 1987 | |
| 50-18-0 6055-19-2 |
Cyclophosphamide | 1 | 26, Sup 7, 100A | 2012 | |
| 50-29-3 | DDT (4,4′-Dichlorodiphenyltrichloroethane) | 2A | Sup 7, 53, 113 | In prep. | |
| 50-32-8 | Benzo[a]pyrene | 1 | Sup 7, 92, 100F | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 50-33-9 | Phenylbutazone | 3 | 13, Sup 7 | 1987 | |
| 50-41-9 | Clomiphene citrate | 3 | 21, Sup 7 | 1987 | |
| 50-44-2 | 6-Mercaptopurine | 3 | 26, Sup 7 | 1987 | |
| 50-55-5 | Reserpine | 3 | 24, Sup 7 | 1987 | |
| 50-76-0 | Actinomycin D | 3 | 10, Sup 7 | 1987 | |
| 51-02-5 | Pronetalol hydrochloride | 3 | 13, Sup 7 | 1987 | |
| 51-03-6 | Piperonyl butoxide | 3 | 30, Sup 7 | 1987 | |
| 51-18-3 | 2,4,6-Tris(1-aziridinyl)-s-triazine | 3 | 9, Sup 7 | 1987 | |
| 51-21-8 | 5-Fluorouracil | 3 | 26, Sup 7 | 1987 | |
| 51-52-5 | Propylthiouracil | 2B | Sup 7, 79 | 2001 | |
| 51-75-2 | Nitrogen mustard | 2A | 9, Sup 7 | 1987 | |
| 51-79-6 | Ethyl carbamate (Urethane) | 2A | 7, Sup 7, 96 | 2010 | |
| 52-01-7 | Spironolactone | 3 | Sup 7, 79 | 2001 | |
| 52-24-4 | Thiotepa | 1 | Sup 7, 50, 100A | 2012 | |
| 52-46-0 | Apholate | 3 | 9, Sup 7 | 1987 | |
| 52-68-6 | Trichlorfon | 3 | 30, Sup 7 | 1987 | |
| 53-03-2 | Prednisone | 3 | 26, Sup 7 | 1987 | |
| 53-70-3 | Dibenz[a,h]anthracene | 2A | Sup 7, 92 | 2010 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 54-05-7 | Chloroquine | 3 | 13, Sup 7 | 1987 | |
| 54-31-9 | Furosemide (Frusemide) | 3 | 50 | 1990 | |
| 54-85-3 | Isonicotinic acid hydrazide (Isoniazid) | 3 | 4, Sup 7 | 1987 | |
| 55-18-5 | N-Nitrosodiethylamine | 2A | 17, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 55-98-1 | 1,4-Butanediol dimethanesulfonate (see Busulfan) | ||||
| 55-98-1 | Busulfan | 1 | 4, Sup 7, 100A | 2012 | |
| 55-98-1 | Myleran (see Busulfan) | ||||
| 56-04-2 | Methylthiouracil | 2B | Sup 7, 79 | 2001 | |
| 56-23-5 | Carbon tetrachloride | 2B | 20, Sup 7, 71 | 1999 | |
| 56-25-7 | Cantharidin | 3 | 10, Sup 7 | 1987 | |
| 56-38-2 | Parathion | 2B | 30, Sup 7, 112 | In prep. | |
| 56-53-1 | Diethylstilbestrol | 1 | 21, Sup 7, 100A | 2012 | |
| 56-55-3 | Benz[a]anthracene | 2B | 92, Sup 7 | 2010 | |
| 56-75-7 | Chloramphenicol | 2A | Sup 7, 50 | 1990 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 57-06-7 | Allyl isothiocyanate | 3 | 73, Sup 7 | 1999 | |
| 57-14-7 | 1,1-Dimethylhydrazine | 2B | 4, Sup 7, 71 | 1999 | |
| 57-39-6 | Tris(2-methyl-1-aziridinyl)phosphine oxide | 3 | 9, Sup 7 | 1987 | |
| 57-41-0 | Phenytoin | 2B | Sup 7, 66 | 1996 | |
| 57-57-8 | beta-Propiolactone | 2B | 4, Sup 7, 71 | 1999 | |
| 57-68-1 | Sulfamethazine | 3 | 79 | 2001 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 57-74-9 | Chlordane | 2B | Sup 7, 53, 79 | 2001 | |
| 57-88-5 | Cholesterol | 3 | 31, Sup 7 | 1987 | |
| 58-08-2 | Caffeine | 3 | 51 | 1991 | |
| 58-14-0 | Pyrimethamine | 3 | 13, Sup 7 | 1987 | |
| 58-55-9 | Theophylline | 3 | 51 | 1991 | |
| 58-89-9 | Lindane (see also Hexachlorocyclohexanes) | 1 | 113 | In prep. | |
| 58-93-5 | Hydrochlorothiazide | 2B | 50, 108 | in prep | |
| 59-05-2 | Methotrexate | 3 | 26, Sup 7 | 1987 | |
| 59-87-0 | Nitrofural (Nitrofurazone) | 3 | 50 | 1990 | |
| 59-89-2 | N-Nitrosomorpholine | 2B | 17, Sup 7 | 1987 | |
| 60-09-3 | para-Aminoazobenzene | 2B | 8, Sup 7 | 1987 | |
| 60-11-7 | para-Dimethylaminoazobenzene | 2B | 8, Sup 7 | 1987 | |
| 60-35-5 | Acetamide | 2B | 7, Sup 7, 71 | 1999 | |
| 60-56-0 | Methimazole | 3 | 79 | 2001 | |
| 60-57-1 | Dieldrin | 3 | 5, Sup 7 | 1987 | |
| 61-57-4 | Niridazole | 2B | 13, Sup 7 | 1987 | |
| 61-82-5 | Amitrole | 3 | 79, Sup 7 | 2001 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 62-44-2 | Phenacetin | 1 | 24, Sup 7, 100A | 2012 | NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data |
| 62-50-0 | Ethyl methanesulfonate | 2B | 7, Sup 7 | 1987 | |
| 62-53-3 | Aniline | 3 | 27, Sup 7 | 1987 | |
| 62-55-5 | Thioacetamide | 2B | 7, Sup 7 | 1987 | |
| 62-56-6 | Thiourea | 3 | Sup 7, 79 | 2001 | |
| 62-73-7 | Dichlorvos | 2B | Sup 7, 53 | 1991 | |
| 62-75-9 | N-Nitrosodimethylamine | 2A | 17, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 63-25-2 | Carbaryl | 3 | 12, Sup 7 | 1987 | |
| 63-92-3 | Phenoxybenzamine hydrochloride | 2B | 24, Sup 7 | 1987 | |
| 64-17-5 | Ethanol in alcoholic beverages | 1 | 96, 100E | 2012 | |
| 64-67-5 | Diethyl sulfate | 2A | 54, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 66-27-3 | Methyl methanesulfonate | 2A | 7, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 66-75-1 | Uracil mustard | 2B | 9, Sup 7 | 1987 | |
| 67-20-9 | Nitrofurantoin | 3 | 50 | 1990 | |
| 67-45-8 | Furazolidone | 3 | 31, Sup 7 | 1987 | |
| 67-63-0 | Isopropyl alcohol | 3 | 15, Sup 7, 71 | 1999 | |
| 67-66-3 | Chloroform | 2B | Sup 7, 73 | 1999 | |
| 67-72-1 | Hexachloroethane | 2B | 73 | 1999 | |
| 68-12-2 | Dimethylformamide | 3 | 47, 71 | 1999 | |
| 68-76-8 | Tris(aziridinyl)-para-benzoquinone (Triaziquone) | 3 | 9, Sup 7 | 1987 | |
| 69-53-4 | Ampicillin | 3 | 50 | 1990 | |
| 70-25-7 | N-Methyl-N´-nitro-N-nitrosoguanidine (MNNG) | 2A | 4, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 70-30-4 | Hexachlorophene | 3 | 20, Sup 7 | 1987 | |
| 71-43-2 | Benzene | 1 | 29, Sup 7. 100F | 2012 | |
| 71-55-6 | 1,1,1-Trichloroethane | 3 | 20, Sup 7, 71 | 1999 | |
| 71-58-9 | Medroxyprogesterone acetate | 2B | 21, Sup 7 | 1987 | |
| 72-20-8 | Endrin | 3 | 5, Sup 7 | 1987 | |
| 72-43-5 | Methoxychlor | 3 | 20, Sup 7 | 1987 | |
| 72-57-1 | Trypan blue | 2B | 8, Sup 7 | 1987 | |
| 74-83-9 | Methyl bromide | 3 | 41, Sup 7, 71 | 1999 | |
| 74-85-1 | Ethylene | 3 | Sup 7, 60 | 1994 | |
| 74-87-3 | Methyl chloride | 3 | 41, Sup 7, 71 | 1999 | |
| 74-88-4 | Methyl iodide | 3 | 41, Sup 7, 71 | 1999 | |
| 74-96-4 | Bromoethane | 3 | 52, 71 | 1999 | |
| 75-00-3 | Chloroethane | 3 | 52, 71 | 1999 | |
| 75-01-4 | Vinyl chloride | 1 | Sup 7, 97, 100F | 2012 | |
| 75-02-5 | Vinyl fluoride | 2A | Sup 7, 63, 97 | 2008 | NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl fluoride should be considered to act similarly to the human carcinogen vinyl chloride |
| 75-07-0 | Acetaldehyde | 2B | 36, Sup 7, 71 | 1999 | |
| 75-07-0 | Acetaldehyde associated with consumption of alcoholic beverages | 1 | 100E | 2012 | |
| 75-09-2 | Dichloromethane (Methylene chloride) | 2A | Sup 7, 71, 110 | In prep. | |
| 75-21-8 | Ethylene oxide | 1 | Sup 7, 60, 97, 100F | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 75-25-2 | Bromoform | 3 | 52, 71 | 1999 | |
| 75-27-4 | Bromodichloromethane | 2B | 52, 71 | 1999 | |
| 75-35-4 | Vinylidene chloride | 3 | 39, Sup 7, 71 | 1999 | |
| 75-38-7 | Vinylidene fluoride | 3 | 39, Sup 7, 71 | 1999 | |
| 75-45-6 | Chlorodifluoromethane | 3 | 41, Sup 7, 71 | 1999 | |
| 75-52-5 | Nitromethane | 2B | 77 | 2000 | |
| 75-55-8 | 2-Methylaziridine (Propyleneimine) | 2B | 9, Sup 7, 71 | 1999 | |
| 75-56-9 | Propylene oxide | 2B | Sup 7, 60 | 1994 | |
| 75-60-5 | Dimethylarsinic acid | 2B | 100C | 2012 | |
| 75-87-6 | Chloral | 2A | 63, 84, 106 | 2014 | |
| 75-88-7 | 2-Chloro-1,1,1-trifluoroethane | 3 | 41, Sup 7, 71 | 1999 | |
| 76-01-7 | Pentachloroethane | 3 | 41, Sup 7, 71 | 1999 | |
| 76-03-9 | Trichloroacetic acid | 2B | 63, 84, 106 | 2014 | |
| 76-44-8 | Heptachlor | 2B | Sup 7, 53, 79 | 2001 | |
| 77-09-8 | Phenolphthalein | 2B | 76 | 2000 | |
| 77-78-1 | Dimethyl sulfate | 2A | 4, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 78-79-5 | Isoprene | 2B | 60, 71 | 1999 | |
| 78-87-5 | 1,2-Dichloropropane | 1 | 41, Sup 7, 71, 110 | In prep. | |
| 78-98-8 | Methylglyoxal | 3 | 51 | 1991 | |
| 79-00-5 | 1,1,2-Trichloroethane | 3 | 52, 71 | 1999 | |
| 79-01-6 | Trichloroethylene | 1 | Sup 7, 63, 106 | 2014 | |
| 79-06-1 | Acrylamide | 2A | 60, Sup 7 | 1994 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 79-10-7 | Acrylic acid | 3 | 19, Sup 7, 71 | 1999 | |
| 79-34-5 | 1,1,2,2-Tetrachloroethane | 2B | 20, Sup 7, 71, 106 | 2014 | |
| 79-43-6 | Dichloroacetic acid | 2B | 63, 84, 106 | 2014 | |
| 79-44-7 | Dimethylcarbamoyl chloride | 2A | 12, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 79-46-9 | 2-Nitropropane | 2B | 29, Sup 7, 71 | 1999 | |
| 80-08-0 | Dapsone | 3 | 24, Sup 7 | 1987 | |
| 80-62-6 | Methyl methacrylate | 3 | Sup 7, 60 | 1994 | |
| 81-07-2 | Saccharin and its salts | 3 | Sup 7, 73 | 1999 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 81-15-2 | Musk xylene | 3 | 65 | 1996 | |
| 81-49-2 | 1-Amino-2,4-dibromoanthraquinone | 2B | 101 | 2013 | |
| 81-88-9 | Rhodamine B | 3 | 16, Sup 7 | 1987 | |
| 82-28-0 | 1-Amino-2-methylanthraquinone | 3 | 27, Sup 7 | 1987 | |
| 82-68-8 | Quintozene (Pentachloronitrobenzene) | 3 | 5, Sup 7 | 1987 | |
| 83-32-9 | Acenaphthene | 3 | 92 | 2010 | |
| 83-63-6 | Diacetylaminoazotoluene | 3 | 8, Sup 7 | 1987 | |
| 83-66-9 | Musk ambrette | 3 | 65 | 1996 | |
| 83-67-0 | Theobromine | 3 | 51 | 1991 | |
| 84-65-1 | Anthraquinone | 2B | 101 | 2013 | |
| 85-01-8 | Phenanthrene | 3 | Sup 7, 92 | 2010 | |
| 85-68-7 | Butyl benzyl phthalate | 3 | Sup 7, 73 | 1999 | |
| 85-83-6 | Scarlet Red | 3 | 8, Sup 7 | 1987 | |
| 85-84-7 | Yellow AB | 3 | 8, Sup 7 | 1987 | |
| 85-86-9 | Sudan III | 3 | 8, Sup 7 | 1987 | |
| 86-30-6 | N-Nitrosodiphenylamine | 3 | 27, Sup 7 | 1987 | |
| 86-54-4 | Hydralazine | 3 | 24, Sup 7 | 1987 | |
| 86-57-7 | 1-Nitronaphthalene | 3 | 46 | 1989 | |
| 86-73-7 | Fluorene | 3 | Sup 7, 92 | 2010 | |
| 86-74-8 | Carbazole | 2B | 32, Sup 7, 71, 103 | 2013 | |
| 86-88-4 | 1-Naphthylthiourea (ANTU) | 3 | 30, Sup 7 | 1987 | |
| 87-29-6 | Cinnamyl anthranilate | 3 | Sup 7, 77 | 2000 | |
| 87-62-7 | 2,6-Dimethylaniline (2,6-Xylidine) | 2B | 57 | 1993 | |
| 87-68-3 | Hexachlorobutadiene | 3 | 73 | 1999 | |
| 87-86-5 | Pentachlorophenol (see Polychlorophenols) | 53, 71 | 1999 | ||
| 88-05-1 | 2,4,6-Trimethylaniline | 3 | 27, Sup 7 | 1987 | |
| 88-12-0 | N-Vinyl-2-pyrrolidone | 3 | 19, Sup 7, 71 | 1999 | |
| 88-72-2 | 2-Nitrotoluene | 2A | 101 | 2013 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 88-73-3 121-73-3 100-00-5 |
Chloronitrobenzenes | 3 | 65 | 1996 | |
| 89-82-7 | Pulegone | 2B | 108 | In prep. | |
| 90-04-0 | ortho-Anisidine | 2B | Sup 7, 73 | 1999 | |
| 90-43-7 | ortho-Phenylphenol | 3 | 73 | 1999 | |
| 90-65-3 | Penicillic acid | 3 | 10, Sup 7 | 1987 | |
| 90-94-8 | Michler’s ketone [4,4´-Bis(dimethylamino)benzophenone] | 2B | 99 | 2010 | |
| 91-20-3 | Naphthalene | 2B | 82 | 2002 | |
| 91-23-6 | 2-Nitroanisole | 2B | 65 | 1996 | |
| 91-59-8 | 2-Naphthylamine | 1 | 4, Sup 7, 99, 100F | 2012 | |
| 91-64-5 | Coumarin | 3 | Sup 7, 77 | 2000 | |
| 91-93-0 | 3,3′-Dimethoxybenzidine-4,4′-diisocyanate | 3 | 39, Sup 7 | 1987 | |
| 91-94-1 | 3,3′-Dichlorobenzidine | 2B | 29, Sup 7 | 1987 | |
| 92-67-1 | 4-Aminobiphenyl | 1 | 1, Sup 7, 99, 100F | 2012 | |
| 92-87-5 | Benzidine | 1 | 29, Sup 7, 99, 100F | 2012 | |
| 92-93-3 | 4-Nitrobiphenyl | 3 | 4, Sup 7 | 1987 | |
| 93-15-2 | Methyleugenol | 2B | 101 | 2013 | |
| 94-36-0 | Benzoyl peroxide | 3 | 36, Sup 7, 71 | 1999 | |
| 94-58-6 | Dihydrosafrole | 2B | 10, Sup 7 | 1987 | |
| 94-59-7 | Safrole | 2B | 10, Sup 7 | 1987 | |
| 94-75-7 | 2,4-D (2,4-dichlorophenoxyacetic acid) (See also Chlorophenoxy herbicides) | 2B | 113 | In prep. | |
| 95-06-7 | Sulfallate | 2B | 30, Sup 7 | 1987 | |
| 95-50-1 | ortho-Dichlorobenzene | 3 | Sup 7, 73 | 1999 | |
| 95-53-4 | ortho-Toluidine | 1 | Sup 7, 77, 99, 100F | 2012 | |
| 95-68-1 | 2,4-Xylidine | 3 | 16, Sup 7 | 1987 | |
| 95-69-2 | 4-Chloro-ortho-toluidine | 2A | 77, 99 | 2010 | |
| 95-70-5 | 2,5-Diaminotoluene | 3 | 16, Sup 7 | 1987 | |
| 95-78-3 | 2,5-Xylidine | 3 | 16, Sup 7 | 1987 | |
| 95-79-4 | 5-Chloro-ortho-toluidine | 3 | 77, 99 | 2010 | |
| 95-80-7 | 2,4-Diaminotoluene | 2B | 16, Sup 7 | 1987 | |
| 95-83-0 | 4-Chloro-ortho-phenylenediamine | 2B | 27, Sup 7 | 1987 | |
| 96-09-3 | Styrene-7,8-oxide | 2A | Sup 7, 60 | 1994 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 96-12-8 | 1,2-Dibromo-3-chloropropane | 2B | 20, Sup 7, 71 | 1999 | |
| 96-13-9 | 2,3-Dibromopropan-1-ol | 2B | 77 | 2000 | |
| 96-18-4 | 1,2,3-Trichloropropane | 2A | 63 | 1995 | |
| 96-23-1 | 1,3-Dichloro-2-propanol | 2B | 101 | 2013 | |
| 96-24-2 | 3-Monochloro-1,2-propanediol | 2B | 101 | 2013 | |
| 96-33-3 | Methyl acrylate | 3 | 39, Sup 7, 71 | 1999 | |
| 96-45-7 | Ethylenethiourea | 3 | Sup 7, 79 | 2001 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 96-48-0 | gamma-Butyrolactone | 3 | 11, Sup 7, 71 | 1999 | |
| 97-53-0 | Eugenol | 3 | 36, Sup 7 | 1987 | |
| 97-56-3 | ortho-Aminoazotoluene | 2B | 8, Sup 7 | 1987 | |
| 97-77-8 | Disulfiram | 3 | 12, Sup 7 | 1987 | |
| 98-01-1 | Furfural | 3 | 63 | 1995 | |
| 98-82-8 | Cumene | 2B | 101 | 2013 | |
| 98-83-9 | a-Methylstyrene | 2B | 101 | 2013 | |
| 98-87-3 98-07-7 100-44-7 98-88-4 |
alpha-Chlorinated toluenes (benzal chloride, benzotrichloride, benzyl chloride) and benzoyl chloride (combined exposures) | 2A | 29, Sup 7, 71 | 1999 | |
| 98-95-3 | Nitrobenzene | 2B | 65 | 1996 | |
| 99-08-1 99-99-0 |
Nitrotoluenes | 3 | 65 | 1996 | |
| 99-55-8 | 5-Nitro-ortho-toluidine | 3 | 48 | 1990 | |
| 99-56-9 | 1,2-Diamino-4-nitrobenzene | 3 | 16, Sup 7 | 1987 | |
| 99-57-0 | 2-Amino-4-nitrophenol | 3 | 57 | 1993 | |
| 99-59-2 | 5-Nitro-ortho-anisidine | 3 | 27, Sup 7 | 1987 | |
| 99-80-9 | N-Methyl-N,4-dinitrosoaniline | 3 | 1, Sup 7 | 1987 | |
| 100-40-3 | 4-Vinylcyclohexene | 2B | Sup 7, 60 | 1994 | |
| 100-41-4 | Ethylbenzene | 2B | 77 | 2000 | |
| 100-42-5 | Styrene | 2B | 60, 82 | 2002 | |
| 100-75-4 | N-Nitrosopiperidine | 2B | 17, Sup 7 | 1987 | |
| 101-14-4 | 4,4′-Methylenebis(2-chloroaniline) (MOCA) | 1 | Sup 7, 57, 99, 100F | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 101-21-3 | Chloropropham | 3 | 12, Sup 7 | 1987 | |
| 101-25-7 | Dinitrosopentamethylenetetramine | 3 | 11, Sup 7 | 1987 | |
| 101-61-1 | Michler’s base [4,4´-methylenebis(N,N-dimethyl)benzenamine] | 2B | 27, Sup 7, 99 | 2010 | |
| 101-68-8 | 4,4′-Methylenediphenyl diisocyanate | 3 | 19, Sup 7, 71 | 1999 | |
| 101-77-9 | 4,4′-Methylenedianiline | 2B | 39, Sup 7 | 1987 | |
| 101-80-4 | 4,4′-Diaminodiphenyl ether | 2B | 29, Sup 7 | 1987 | |
| 101-90-6 | Diglycidyl resorcinol ether | 2B | 36, Sup 7, 71 | 1999 | |
| 102-50-1 | meta-Cresidine | 3 | 27, Sup 7 | 1987 | |
| 102-71-6 | Triethanolamine | 3 | 77 | 2000 | |
| 103-03-7 | Phenicarbazide | 3 | 12, Sup 7 | 1987 | |
| 103-11-7 | 2-Ethylhexyl acrylate | 3 | 60 | 1994 | |
| 103-23-1 | Di(2-ethylhexyl) adipate | 3 | Sup 7, 77 | 2000 | |
| 103-33-3 | Azobenzene | 3 | 8, Sup 7 | 1987 | |
| 103-90-2 | Acetaminophen (see Paracetamol) | ||||
| 103-90-2 | Paracetamol (Acetaminophen) | 3 | 50, 73 | 1999 | |
| 104-94-9 | para-Anisidine | 3 | 27, Sup 7 | 1987 | |
| 105-11-3 | para-Benzoquinone dioxime | 3 | 29, Sup 7, 71 | 1999 | |
| 105-55-5 | N,N‘-Diethylthiourea | 3 | 79 | 2001 | |
| 105-60-2 | Caprolactam | 4 | 39, Sup 7, 71 | 1999 | |
| 105-74-8 | Lauroyl peroxide | 3 | 36, Sup 7, 71 | 1999 | |
| 106-46-7 | para-Dichlorobenzene | 2B | Sup 7, 73 | 1999 | |
| 106-47-8 | para-Chloroaniline | 2B | 57 | 1993 | |
| 106-50-3 | para-Phenylenediamine | 3 | 16, Sup 7 | 1987 | |
| 106-51-4 | para-Quinone | 3 | 15, Sup 7, 71 | 1999 | |
| 106-87-6 | 4-Vinylcyclohexene diepoxide | 2B | Sup 7, 60 | 1994 | |
| 106-88-7 | 1,2-Epoxybutane | 2B | 47, 71 | 1999 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data |
| 106-89-8 | Epichlorohydrin | 2A | 11, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 106-93-4 | Ethylene dibromide | 2A | 15, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 106-99-0 | 1,3-Butadiene | 1 | Sup 7, 54, 71, 97, 100F | 2012 | |
| 107-02-8 | Acrolein | 3 | 63, Sup 7 | 1995 | |
| 107-05-1 | Allyl chloride | 3 | 36, Sup 7, 71 | 1999 | |
| 107-06-2 | 1,2-Dichloroethane | 2B | 20, Sup 7, 71 | 1999 | |
| 107-13-1 | Acrylonitrile | 2B | 71 | 1999 | |
| 107-14-2 | Chloroacetonitrile | 3 | 52, 71 | 1999 | |
| 107-30-2 | Chloromethyl methyl ether (see Bis(chloromethyl)ether; chloromethyl methyl ether) | ||||
| 108-05-4 | Vinyl acetate | 2B | Sup 7, 63 | 1995 | |
| 108-10-1 | Methyl isobutyl ketone | 2B | 101 | 2013 | |
| 108-30-5 | Succinic anhydride | 3 | 15, Sup 7 | 1987 | |
| 108-45-2 | meta-Phenylenediamine | 3 | 16, Sup 7 | 1987 | |
| 108-46-3 | Resorcinol | 3 | 15, Sup 7, 71 | 1999 | |
| 108-60-1 | Bis(2-chloro-1-methylethyl)ether | 3 | 41, Sup 7, 71 | 1999 | |
| 108-78-1 | Melamine | 3 | Sup 7, 73 | 1999 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 108-88-3 | Toluene | 3 | 47, 71 | 1999 | |
| 108-94-1 | Cyclohexanone | 3 | 47, 71 | 1999 | |
| 108-95-2 | Phenol | 3 | 47, 71 | 1999 | |
| 110-00-9 | Furan | 2B | 63 | 1995 | |
| 110-57-6 | trans-1,4-Dichlorobutene | 3 | 15, Sup 7, 71 | 1999 | |
| 110-86-1 | Pyridine | 3 | 77 | 2000 | |
| 110-91-8 | Morpholine | 3 | 47, 71 | 1999 | |
| 111-42-2 | Diethanolamine | 2B | 77, 101 | 2013 | |
| 111-44-4 | Bis(2-chloroethyl)ether | 3 | 9, Sup 7, 71 | 1999 | |
| 111-76-2 | 2-Butoxyethanol | 3 | 88 | 2006 | |
| 115-02-6 | Azaserine | 2B | 10, Sup 7 | 1987 | |
| 115-07-1 | Propylene | 3 | Sup 7, 60 | 1994 | |
| 115-28-6 | Chlorendic acid | 2B | 48 | 1990 | |
| 115-32-2 | Dicofol | 3 | 30, Sup 7 | 1987 | |
| 115-96-8 | Tris(2-chloroethyl) phosphate | 3 | 48, 71 | 1999 | |
| 116-06-3 | Aldicarb | 3 | 53 | 1991 | |
| 116-14-3 | Tetrafluoroethylene | 2A | 19, Sup 7, 71, 110 | In prep. | NB: Overall evaluation upgraded to Group 2A on the basis of sufficient evidence in experimental animals with a striking and atypical pattern of tumours |
| 117-10-2 | Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) | 2B | 50 | 1990 | |
| 117-39-5 | Quercetin | 3 | Sup 7, 73 | 1999 | |
| 117-79-3 | 2-Aminoanthraquinone | 3 | 27, Sup 7 | 1987 | |
| 117-81-7 | Bis(2-ethylhexyl) phthalate (see Di(2-ethylhexyl) phthalate) | ||||
| 117-81-7 | Di(2-ethylhexyl)phthalate | 2B | Sup 7, 77, 101 | 2013 | |
| 118-74-1 | Hexachlorobenzene | 2B | Sup 7, 79 | 2001 | |
| 118-92-3 | Anthranilic acid | 3 | 16, Sup 7 | 1987 | |
| 118-96-7 | 2,4,6-Trinitrotoluene | 3 | 65 | 1996 | |
| 119-34-6 | 4-Amino-2-nitrophenol | 3 | 16, Sup 7 | 1987 | |
| 119-61-9 | Benzophenone | 2B | 101 | 2013 | |
| 119-90-4 | 3,3′-Dimethoxybenzidine (ortho-Dianisidine) | 2B | 4, Sup 7 | 1987 | |
| 119-93-7 | 3,3′-Dimethylbenzidine (ortho-Tolidine) | 2B | 1, Sup 7 | 1987 | |
| 120-12-7 | Anthracene | 3 | 92, Sup 7 | 2010 | |
| 120-58-1 | Isosafrole | 3 | 10, Sup 7 | 1987 | |
| 120-71-8 | para-Cresidine | 2B | 27, Sup 7 | 1987 | |
| 120-80-9 | Catechol | 2B | 15, Sup 7, 71 | 1999 | |
| 121-14-2 | 2,4-Dinitrotoluene | 2B | 65 | 1996 | |
| 121-66-4 | 2-Amino-5-nitrothiazole | 3 | 31, Sup 7 | 1987 | |
| 121-69-7 | N,N-Dimethylaniline | 3 | 57 | 1993 | |
| 121-75-5 | Malathion | 2A | 30, Sup 7, 112 | In prep. | |
| 121-88-0 | 2-Amino-5-nitrophenol | 3 | 57 | 1993 | |
| 122-34-9 | Simazine | 3 | 53, 73 | 1999 | |
| 122-42-9 | Propham | 3 | 12, Sup 7 | 1987 | |
| 122-60-1 | Phenyl glycidyl ether | 2B | 47, 71 | 1999 | |
| 123-31-9 | Hydroquinone | 3 | 15, Sup 7, 71 | 1999 | |
| 123-33-1 | Maleic hydrazide | 3 | 4, Sup 7 | 1987 | |
| 123-91-1 | 1,4-Dioxane | 2B | 11, Sup 7, 71 | 1999 | |
| 124-48-1 | Chlorodibromomethane | 3 | 52, 71 | 1999 | |
| 124-58-3 | Methylarsonic acid | 2B | 100C | 2012 | |
| 124-58-3 | Monomethylarsonic acid (see Methylarsonic acid) | 2B | 100C | 2012 | |
| 125-33-7 | Primidone | 2B | 108 | In prep. | |
| 126-07-8 | Griseofulvin | 2B | Sup 7, 79 | 2001 | |
| 126-72-7 | Tris(2,3-dibromopropyl) phosphate | 2A | 20, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 126-85-2 | Nitrogen mustard N-oxide | 2B | 9, Sup 7 | 1987 | |
| 126-99-8 | Chloroprene | 2B | Sup 7, 71 | 1999 | |
| 127-07-1 | Hydroxyurea | 3 | 76 | 2000 | |
| 127-18-4 | Tetrachloroethylene (Perchloroethylene) | 2A | Sup 7, 63, 106 | 2014 | |
| 127-69-5 | Sulfafurazole (Sulfisoxazole) | 3 | 24, Sup 7 | 1987 | |
| 128-37-0 | Butylated hydroxytoluene (BHT) | 3 | 40, Sup 7 | 1987 | |
| 128-66-5 | Vat Yellow 4 | 3 | 48 | 1990 | |
| 129-00-0 | Pyrene | 3 | Sup 7, 92 | 2010 | |
| 129-15-7 | 2-Methyl-1-nitroanthraquinone (uncertain purity) | 2B | 27, Sup 7 | 1987 | |
| 129-17-9 | Blue VRS | 3 | 16, Sup 7 | 1987 | |
| 129-20-4 | Oxyphenbutazone | 3 | 13, Sup 7 | 1987 | |
| 129-43-1 | 1-Hydroxyanthraquinone | 2B | 82 | 2002 | |
| 131-79-3 | Yellow OB | 3 | 8, Sup 7 | 1987 | |
| 132-27-4 | Sodium ortho-phenylphenate | 2B | Sup 7, 73 | 1999 | |
| 132-65-0 | Dibenzothiophene | 3 | 103 | 2013 | |
| 133-06-2 | Captan | 3 | 30, Sup 7 | 1987 | |
| 134-32-7 | 1-Naphthylamine | 3 | 4, Sup 7 | 1987 | |
| 135-88-6 | N-Phenyl-2-naphthylamine | 3 | 16, Sup 7 | 1987 | |
| 136-40-3 | Phenazopyridine hydrochloride | 2B | 24, Sup 7 | 1987 | |
| 137-17-7 | 2,4,5-Trimethylaniline | 3 | 27, Sup 7 | 1987 | |
| 137-26-8 | Thiram | 3 | Sup 7, 53 | 1991 | |
| 137-30-4 | Ziram | 3 | Sup 7, 53 | 1991 | |
| 138-59-0 | Shikimic acid | 3 | 40, Sup 7 | 1987 | |
| 139-05-9 | Cyclamates (sodium cyclamate) | 3 | Sup 7, 73 | 1999 | |
| 139-13-9 | Nitrilotriacetic acid and its salts | 2B | 48, 73 | 1999 | NB: Evaluated as a group |
| 139-65-1 | 4,4′-Thiodianiline | 2B | 27, Sup 7 | 1987 | |
| 139-94-6 | Nithiazide | 3 | 31, Sup 7 | 1987 | |
| 140-11-4 | Benzyl acetate | 3 | 40, Sup 7, 71 | 1999 | |
| 140-56-7 | para-Dimethylaminoazobenzenediazo sodium sulfonate | 3 | 8, Sup 7 | 1987 | |
| 140-57-8 | Aramite® | 2B | 5, Sup 7 | 1987 | |
| 140-88-5 | Ethyl acrylate | 2B | 39, Sup 7, 71 | 1999 | |
| 141-32-2 | n-Butyl acrylate | 3 | 39, Sup 7, 71 | 1999 | |
| 141-37-7 | 3,4-Epoxy-6-methylcyclohexylmethyl-3,4-epoxy-6-methylcyclo-hexanecarboxylate | 3 | 11, Sup 7, 71 | 1999 | |
| 141-90-2 | Thiouracil | 2B | Sup 7, 79 | 2001 | |
| 142-83-6 | 2,4-Hexadienal | 2B | 101 | 2013 | |
| 143-50-0 | Chlordecone (Kepone) | 2B | 20, Sup 7 | 1987 | |
| 143-67-9 | Vinblastine sulfate | 3 | 26, Sup 7 | 1987 | |
| 144-34-3 | Methyl selenac | 3 | 12, Sup 7 | 1987 | |
| 148-18-5 | Sodium diethyldithiocarbamate | 3 | 12, Sup 7 | 1987 | |
| 148-24-3 | 8-Hydroxyquinoline | 3 | 13, Sup 7 | 1987 | |
| 148-82-3 | Melphalan | 1 | 9, Sup 7, 100A | 2012 | |
| 149-29-1 | Patulin | 3 | 40, Sup 7 | 1987 | |
| 150-13-0 | para-Aminobenzoic acid | 3 | 16, Sup 7 | 1987 | |
| 150-68-5 | Monuron | 3 | Sup 7, 53 | 1991 | |
| 150-69-6 | Dulcin | 3 | 12, Sup 7 | 1987 | |
| 151-56-4 | Aziridine | 2B | 9, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data |
| 154-93-8 | Bischloroethyl nitrosourea (BCNU) | 2A | 26, Sup 7 | 1987 | |
| 156-10-5 | para-Nitrosodiphenylamine | 3 | 27, Sup 7 | 1987 | |
| 156-51-4 | Phenelzine sulfate | 3 | 24, Sup 7 | 1987 | |
| 189-55-9 | Dibenzo[a,i]pyrene | 2B | 92 | 2010 | |
| 189-64-0 | Dibenzo[a,h]pyrene | 2B | Sup 7, 92 | 2010 | |
| 191-07-1 | Coronene | 3 | 32, Sup 7, 92 | 1987 | |
| 191-24-2 | Benzo[ghi]perylene | 3 | 92, Sup 7 | 2010 | |
| 191-26-4 | Anthanthrene | 3 | 92, Sup 7 | 2010 | |
| 191-30-0 | Dibenzo[a,l]pyrene | 2A | Sup 7, 92 | 2010 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 192-47-2 | Dibenzo[h,rst]pentaphene | 3 | Sup 7, 92 | 2010 | |
| 192-51-8 | Dibenzo[e,l]pyrene | 3 | 92 | 2010 | |
| 192-65-4 | Dibenzo[a,e]pyrene | 3 | Sup 7, 92 | 2010 | |
| 192-97-2 | Benzo[e]pyrene | 3 | 92, Sup 7 | 2010 | |
| 193-09-9 | Naphtho[2,3-e]pyrene | 3 | 92 | 2010 | |
| 193-39-5 | Indeno[1,2,3-cd]pyrene | 2B | Sup 7, 92 | 2010 | |
| 194-59-2 | 7H-Dibenzo[c,g]carbazole | 2B | 32, Sup 7, 103 | 2013 | |
| 195-19-7 | Benzo[c]phenanthrene | 2B | 92, Sup 7 | 2010 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data |
| 196-78-1 | Benzo[g]chrysene | 3 | 92 | 2010 | |
| 198-55-0 | Perylene | 3 | Sup 7, 92 | 2010 | |
| 202-33-5 | Benz[j]aceanthrylene | 2B | 92 | 2010 | NB: Overall evaluation upgraded to Group 2B with supporting mechanistic and other relevant data |
| 202-94-8 | 11H-Benz[bc]aceanthrylene | 3 | 92 | 2010 | |
| 202-98-2 | 4H-Cyclopenta[def]chrysene | 3 | 92 | 2010 | |
| 203-12-3 | Benzo[ghi]fluoranthene | 3 | 92, Sup 7 | 2010 | |
| 203-20-3 | Naphtho[2,1-a]fluoranthene | 3 | 92 | 2010 | |
| 203-33-8 | Benzo[a]fluoranthene | 3 | 92, Sup 7 | 2010 | |
| 205-12-9 | Benzo[c]fluorene | 3 | 92, Sup 7 | 2010 | |
| 205-82-3 | Benzo[j]fluoranthene | 2B | 92 | 2010 | |
| 205-99-2 | Benzo[b]fluoranthene | 2B | 92 | 2010 | |
| 206-44-0 | Fluoranthene | 3 | Sup 7, 92 | 2010 | |
| 207-08-9 | Benzo[k]fluoranthene | 2B | 92 | 2010 | |
| 207-83-0 | 13H-Dibenzo[a,g]fluorene | 3 | 92 | 2010 | |
| 211-91-6 | Benz[l]aceanthrylene | 3 | 92 | 2010 | |
| 213-46-7 | Picene | 3 | 92 | 2010 | |
| 214-17-5 | Benzo[b]chrysene | 3 | 92 | 2010 | |
| 215-58-7 | Dibenz[a,c]anthracene | 3 | Sup 7, 92 | 2010 | |
| 217-59-4 | Triphenylene | 3 | Sup 7, 92 | 2010 | |
| 218-01-9 | Chrysene | 2B | 92 | 2010 | |
| 224-41-9 | Dibenz[a,j]anthracene | 3 | Sup 7, 92 | 2010 | |
| 224-42-0 | Dibenz[a,j]acridine | 2A | 32, Sup 7, 103 | 2013 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 224-53-3 | Dibenz[c,h]acridine | 2B | 103 | 2013 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data |
| 225-11-6 | Benz[a]acridine | 3 | 32, Sup 7, 103 | 2013 | |
| 225-51-4 | Benz[c]acridine | 3 | 32, Sup 7, 103 | 2013 | |
| 226-36-8 | Dibenz[a,h]acridine | 2B | 32, Sup 7, 103 | 2013 | |
| 238-84-6 | Benzo[a]fluorene | 3 | 92, Sup 7 | 2010 | |
| 239-35-0 | Benzo[b]naphtho[2,1-d]thiophene | 3 | 103 | 2013 | |
| 243-17-4 | Benzo[b]fluorene | 3 | 92, Sup 7 | 2010 | |
| 262-12-4 | Dibenzo-para-dioxin | 3 | 69 | 1997 | |
| 271-89-6 | Benzofuran | 2B | 63 | 1995 | |
| 298-00-0 | Methyl parathion | 3 | 30, Sup 7 | 1987 | |
| 298-81-7 | Methoxsalen (8-methoxypsoralen) plus ultraviolet A radiation | 1 | 24, Sup 7, 100A | 2012 | |
| 299-75-2 | Treosulfan | 1 | 26, Sup 7, 100A | 2012 | |
| 302-01-2 | Hydrazine | 2B | 4, Sup 7, 71 | 1999 | |
| 302-17-0 | Chloral hydrate | 2A | 63, 84, 106 | 2014 | |
| 303-34-4 | Lasiocarpine | 2B | 10, Sup 7 | 1987 | |
| 303-47-9 | Ochratoxin A | 2B | Sup 7, 56 | 1993 | |
| 305-03-3 | Chlorambucil | 1 | 26, Sup 7, 100A | 2012 | |
| 309-00-2 | Aldrin | 3 | 5, Sup 7 | 1987 | |
| 313-67-7 | Aristolochic acid | 1 | 82, 100A | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 313-67-7 | Aristolochic acid, plants containing | 1 | 82, 100A | 2012 | |
| 314-13-6 | Evans blue | 3 | 8, Sup 7 | 1987 | |
| 315-18-4 | Zectran | 3 | 12, Sup 7 | 1987 | |
| 315-22-0 | Monocrotaline | 2B | 10, Sup 7 | 1987 | |
| 320-67-2 | Azacitidine | 2A | 50 | 1990 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 331-39-5 | Caffeic acid | 2B | 56 | 1993 | |
| 333-41-5 | Diazinon | 2A | 112 | In prep. | NB: Overall evaluation upgraded to Group 2A based on mechanistic evidence |
| 334-88-3 | Diazomethane | 3 | 7, Sup 7 | 1987 | |
| 335-67-1 | Perfluorooctanoic acid | 2B | 110 | In prep. | |
| 366-70-1 | Procarbazine hydrochloride | 2A | 26, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 396-01-0 | Triamterene | 2B | 108 | In prep. | |
| 420-12-2 | Ethylene sulfide | 3 | 11, Sup 7 | 1987 | |
| 439-14-5 | Diazepam | 3 | Sup 7, 66 | 1996 | |
| 443-48-1 | Metronidazole | 2B | 13, Sup 7 | 1987 | |
| 446-86-6 | Azathioprine | 1 | 26, Sup 7, 100A | 2012 | |
| 480-54-6 | Retrorsine | 3 | 10, Sup 7 | 1987 | |
| 480-81-9 | Seneciphylline | 3 | 10, Sup 7 | 1987 | |
| 484-20-8 | 5-Methoxypsoralen | 2A | 40, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 492-17-1 | 2,4′-Diphenyldiamine | 3 | 16, Sup 7 | 1987 | |
| 492-80-8 | Auramine | 2B | 1, Sup 7, 99, 100F | 2012 | |
| 493-52-7 | Methyl red | 3 | 8, Sup 7 | 1987 | |
| 494-03-1 | Chlornaphazine | 1 | 4, Sup 7, 100A | 2012 | |
| 494-03-1 | N,N-Bis(2-chloroethyl)-2-naphthylamine (see Chlornaphazine) | ||||
| 494-38-2 | Acridine orange | 3 | 16, Sup 7 | 1987 | |
| 501-30-4 | Kojic acid | 3 | 79 | 2001 | |
| 505-60-2 | Mustard gas (see Sulfur mustard) | ||||
| 505-60-2 | Sulfur mustard | 1 | 9, Sup 7, 100F | 2012 | |
| 509-14-8 | Tetranitromethane | 2B | 65 | 1996 | |
| 510-15-6 | Chlorobenzilate | 3 | 30, Sup 7 | 1987 | |
| 513-37-1 | 1-Chloro-2-methylpropene | 2B | 63 | 1995 | |
| 518-75-2 | Citrinin | 3 | 40, Sup 7 | 1987 | |
| 520-18-3 | Kaempferol | 3 | 31, Sup 7 | 1987 | |
| 523-44-4 | CI Acid Orange 20 | 3 | 8, Sup 7 | 1987 | |
| 523-44-4 | Orange I (see CI Acid Orange 20) | ||||
| 523-50-2 | Angelicin plus ultraviolet A radiation | 3 | 40, Sup 7 | 1987 | |
| 531-76-0 | Merphalan | 2B | 9, Sup 7 | 1987 | |
| 531-82-8 | N-[4-(5-Nitro-2-furyl)-2-thiazolyl]acetamide | 2B | 7, Sup 7 | 1987 | |
| 532-82-1 | Chrysoidine | 3 | 8, Sup 7 | 1987 | |
| 536-33-4 | Ethionamide | 3 | 13, Sup 7 | 1987 | |
| 540-73-8 | 1,2-Dimethylhydrazine | 2A | 4, Sup 7, 71 | 1999 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 541-73-1 | meta-Dichlorobenzene | 3 | 73 | 1999 | |
| 542-75-6 | 1,3-Dichloropropene (technical-grade) | 2B | 41, Sup 7, 71 | 1999 | |
| 542-78-9 | Malonaldehyde | 3 | 36, Sup 7, 71 | 1999 | |
| 542-88-1 107-30-2 |
Bis(chloromethyl)ether; chloromethyl methyl ether (technical-grade) | 1 | 4, Sup 7, 100F | 2012 | |
| 545-06-2 | Trichloroacetonitrile | 3 | 52, 71 | 1999 | |
| 545-55-1 | Tris(1-aziridinyl)phosphine oxide | 3 | 9, Sup 7 | 1987 | |
| 551-74-6 | Mannomustine dihydrochloride | 3 | 9, Sup 7 | 1987 | |
| 555-84-0 | 1-[(5-Nitrofurfurylidene)amino]-2-imidazolidinone | 2B | 7, Sup 7 | 1987 | |
| 556-52-5 | Glycidol | 2A | 77 | 2000 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 562-10-7 | Doxylamine succinate | 3 | 79 | 2001 | |
| 563-41-7 | Semicarbazide hydrochloride | 3 | 12, Sup 7 | 1987 | |
| 563-47-3 | 3-Chloro-2-methylpropene | 3 | 63 | 1995 | |
| 569-61-9 | CI Basic Red 9 | 2B | 57, 99 | 2010 | |
| 581-89-5 | 2-Nitronaphthalene | 3 | 46 | 1989 | |
| 592-62-1 | Methylazoxymethanol acetate | 2B | 10, Sup 7 | 1987 | |
| 593-60-2 | Vinyl bromide | 2A | 39, Sup 7, 71, 97 | 2008 | NB: (1) Overall evaluation upgraded to Group 2A based on mechanistic and other relevant data; (2) For practical purposes, vinyl bromide should be considered to act similarly to the human carcinogen vinyl chloride |
| 593-70-4 | Chlorofluoromethane | 3 | 41, Sup 7, 71 | 1999 | |
| 598-55-0 | Methyl carbamate | 3 | 12, Sup 7 | 1987 | |
| 599-79-1 | Sulfasalazine | 2B | 108 | In prep. | |
| 602-60-8 | 9-Nitroanthracene | 3 | 33, Sup 7 | 1987 | |
| 602-87-9 | 5-Nitroacenaphthene | 2B | 16, Sup 7 | 1987 | |
| 604-75-1 | Oxazepam | 2B | Sup 7, 66 | 1996 | |
| 606-20-2 | 2,6-Dinitrotoluene | 2B | 65 | 1996 | |
| 607-57-8 | 2-Nitrofluorene | 2B | 46, 105 | 2013 | |
| 609-20-1 | 2,6-Dichloro-para-phenylenediamine | 3 | 39, Sup 7 | 1987 | |
| 613-35-4 | N,N‘-Diacetylbenzidine | 2B | 16, Sup 7 | 1987 | |
| 615-05-4 | 2,4-Diaminoanisole | 2B | Sup 7, 79 | 2001 | |
| 615-53-2 | N-Methyl-N-nitrosourethane | 2B | 4, Sup 7 | 1987 | |
| 618-85-9 | 3,5-Dinitrotoluene | 3 | 65 | 1996 | |
| 621-64-7 | N-Nitrosodi-n-propylamine | 2B | 17, Sup 7 | 1987 | |
| 627-12-3 | n-Propyl carbamate | 3 | 12, Sup 7 | 1987 | |
| 630-20-6 | 1,1,1,2-Tetrachloroethane | 2B | 41, Sup 7, 71, 106 | 2014 | |
| 631-64-1 | Dibromoacetic acid | 2B | 101 | 2013 | |
| 632-99-5 | Magenta | 2B | Sup 7, 57, 99, 100F | 2012 | |
| 637-07-0 | Clofibrate | 3 | Sup 7, 66 | 1996 | |
| 641-48-5 | Dihydroaceanthrylene | 3 | 92 | 2010 | |
| 680-31-9 | Hexamethylphosphoramide | 2B | 15, Sup 7, 71 | 1999 | |
| 684-93-5 | N-Methyl-N-nitrosourea | 2A | 17, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 693-98-1 | 2-Methylimidazole | 2B | 101 | 2013 | |
| 712-68-5 | 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole | 2B | 7, Sup 7 | 1987 | |
| 723-46-6 | Sulfamethoxazole | 3 | Sup 7, 79 | 2001 | |
| 759-73-9 | N-Ethyl-N-nitrosourea | 2A | 17, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 765-34-4 | Glycidaldehyde | 2B | 11, Sup 7, 71 | 1999 | |
| 789-07-1 | 2-Nitropyrene | 3 | 46 | 1989 | |
| 794-93-4 | Dihydroxymethylfuratrizine (see also Panfuran S) | 3 | 24, Sup 7 | 1987 | |
| 794-93-4 | Panfuran S (containing dihydroxymethylfuratrizine) | 2B | 24, Sup 7 | 1987 | |
| 800-24-8 | Aziridyl benzoquinone | 3 | 9, Sup 7 | 1987 | |
| 804-36-4 | Nitrovin | 3 | 31, Sup 7 | 1987 | |
| 817-09-4 | Trichlormethine (Trimustine hydrochloride) | 2B | Sup 7, 50 | 1990 | |
| 822-36-6 | 4-Methylimidazole | 2B | 101 | 2013 | |
| 828-00-2 | Dimethoxane | 3 | 15, Sup 7 | 1987 | |
| 832-69-9 | 1-Methylphenanthrene | 3 | Sup 7, 92 | 2010 | |
| 838-88-0 | 4,4′-Methylene bis(2-methylaniline) | 2B | 4, Sup 7 | 1987 | |
| 842-07-9 | Sudan I | 3 | 8, Sup 7 | 1987 | |
| 846-50-4 | Temazepam | 3 | 66 | 1996 | |
| 868-85-9 | Dimethyl hydrogen phosphite | 3 | 48, 71 | 1999 | |
| 892-21-7 | 3-Nitrofluoranthene | 3 | 33, Sup 7 | 1987 | |
| 915-67-3 | Amaranth | 3 | 8, Sup 7 | 1987 | |
| 924-16-3 | N-Nitrosodi-n-butylamine | 2B | 17, Sup 7 | 1987 | |
| 930-55-2 | N-Nitrosopyrrolidine | 2B | 17, Sup 7 | 1987 | |
| 989-38-8 | Rhodamine 6G | 3 | 16, Sup 7 | 1987 | |
| 1071-83-6 | Glyphosate | 2A | 112 | In prep. | |
| 1072-52-2 | 2-(1-Aziridinyl)ethanol | 3 | 9, Sup 7 | 1987 | |
| 1116-54-7 | N-Nitrosodiethanolamine | 2B | 17, Sup 7, 77 | 2000 | |
| 1120-71-4 | 1,3-Propane sultone | 2A | 4, Sup 7, 71, 110 | In prep. | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 1143-38-0 | Dithranol | 3 | 13; Sup 7 | 1987 | |
| 1163-19-5 | Decabromodiphenyl oxide | 3 | 48, 71 | 1999 | |
| 1303-00-0 | Gallium arsenide (see Arsenic and inorganic arsenic compounds) | 86, 100C | 2012 | ||
| 1309-37-1 | Ferric oxide | 3 | 1, Sup 7 | 1987 | |
| 1309-64-4 | Antimony trioxide | 2B | 47 | 1989 | |
| 1314-62-1 | Vanadium pentoxide | 2B | 86 | 2006 | |
| 1317-60-8 | Haematite | 3 | 1, Sup 7 | 1987 | |
| 1318-02-1 | Zeolites other than erionite (clinoptilolite, phillipsite,mordenite, non-fibrous Japanese zeolite, synthetic zeolites) | 3 | 68 | 1997 | |
| 1330-20-7 | Xylenes | 3 | 47, 71 | 1999 | |
| 1332-21-4 13768-00-8 12172-73-5 17068-78-9 12001-29-5 12001-28-4 14567-73-8 |
Asbestos (all forms, including actinolite, amosite, anthophyllite, chrysotile, crocidolite, tremolite) | 1 | 14, Sup 7, 100C | 2012 | NB: Mineral substances (e.g. talc or vermiculite) that contain asbestos should also be regarded as carcinogenic to humans |
| 1333-86-4 | Carbon black | 2B | Sup 7, 65, 93 | 2010 | |
| 1336-36-3 | Polychlorinated biphenyls | 1 | 18, Sup 7, 107 | In prep. | |
| 1338-16-5 | Iron sorbitol-citric acid complex | 3 | 2, Sup 7 | 1987 | |
| 1345-04-6 | Antimony trisulfide | 3 | 47 | 1989 | |
| 1401-55-4 | Tannic acid and tannins | 3 | 10, Sup 7 | 1987 | |
| 1402-68-2 | Aflatoxins | 1 | 56, 82, 100F, Sup 7 | 2012 | |
| 1464-53-5 | 1,2:3,4-Diepoxybutane (see Monographs on 1,3-Butadiene) | 11, Sup 7 | 1987 | ||
| 1582-09-8 | Trifluralin | 3 | 53 | 1991 | |
| 1615-80-1 | 1,2-Diethylhydrazine | 2B | 4, Sup 7, 71 | 1999 | |
| 1634-04-4 | Methyl tert-butyl ether | 3 | 73 | 1999 | |
| 1675-54-3 | Bisphenol A diglycidyl ether (Araldite) | 3 | 47, 71 | 1999 | |
| 1689-82-3 | 4-Hydroxyazobenzene | 3 | 8, Sup 7 | 1987 | |
| 1694-09-3 | Benzyl violet 4B | 2B | 16, Sup 7 | 1987 | |
| 1705-85-7 | 6-Methylchrysene | 3 | Sup 7, 92 | 2010 | |
| 1706-01-0 | 3-Methylfluoranthene | 3 | Sup 7, 92 | 2010 | |
| 1746-01-6 | 2,3,7,8-Tetrachlorodibenzo-para-dioxin | 1 | Sup 7, 69, 100F | 2012 | |
| 1836-75-5 | Nitrofen (technical-grade) | 2B | 30, Sup 7 | 1987 | |
| 1897-45-6 | Chlorothalonil | 2B | Sup 7, 73 | 1999 | |
| 1912-24-9 | Atrazine | 3 | 53, 73 | 1999 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 1918-02-1 | Picloram | 3 | 53 | 1991 | |
| 1936-15-8 | CI Orange G | 3 | 8, Sup 7 | 1987 | |
| 1936-15-8 | Orange G (see CI Orange G) | ||||
| 1937-37-7 | CI Direct Black 38 (see Benzidine, dyes metabolized to) | ||||
| 1954-28-5 | Triethylene glycol diglycidyl ether | 3 | 11, Sup 7, 71 | 1999 | |
| 2068-78-2 | Vincristine sulfate | 3 | 26, Sup 7 | 1987 | |
| 2164-17-2 | Fluometuron | 3 | 30, Sup 7 | 1987 | |
| 2168-68-5 | Bis(1-aziridinyl)morpholinophosphine sulfide | 3 | 9, Sup 7 | 1987 | |
| 2243-62-1 | 1,5-Naphthalenediamine | 3 | 27, Sup 7 | 1987 | |
| 2303-16-4 | Diallate | 3 | 30, Sup 7 | 1987 | |
| 2318-18-5 | Senkirkine | 3 | 31, Sup 7 | 1987 | |
| 2353-45-9 | Fast Green FCF | 3 | 16, Sup 7 | 1987 | |
| 2385-85-5 | Mirex | 2B | 20, Sup 7 | 1987 | |
| 2386-90-5 | Bis(2,3-epoxycyclopentyl)ether | 3 | 47, 71 | 1999 | |
| 2425-06-1 | Captafol | 2A | 53 | 1991 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 2425-85-6 | CI Pigment Red 3 | 3 | 57 | 1993 | |
| 2429-74-5 | CI Direct Blue 15 | 2B | 57 | 1993 | |
| 2432-99-7 | 11-Aminoundecanoic acid | 3 | 39, Sup 7 | 1987 | |
| 2475-45-8 | Disperse Blue 1 | 2B | 48 | 1990 | |
| 2602-46-2 | CI Direct Blue 6 (see Benzidine, dyes metabolized to) | ||||
| 2646-17-5 | Oil Orange SS | 2B | 8, Sup 7 | 1987 | |
| 2757-90-6 | Agaritine | 3 | 31, Sup 7 | 1987 | |
| 2783-94-0 | Sunset Yellow FCF | 3 | 8, Sup 7 | 1987 | |
| 2784-94-3 | HC Blue No. 1 | 2B | 57 | 1993 | |
| 2832-40-8 | Disperse Yellow 3 | 3 | 48 | 1990 | |
| 2835-39-4 | Allyl isovalerate | 3 | 36, Sup 7, 71 | 1999 | |
| 2871-01-4 | HC Red No. 3 | 3 | 57 | 1993 | |
| 2955-38-6 | Prazepam | 3 | 66 | 1996 | |
| 2973-10-6 | Diisopropyl sulfate | 2B | 54, 71 | 1999 | |
| 3018-12-0 | Dichloroacetonitrile | 3 | 52, 71 | 1999 | |
| 3068-88-0 | beta-Butyrolactone | 2B | 11, Sup 7, 71 | 1999 | |
| 3118-97-6 | Sudan II | 3 | 8, Sup 7 | 1987 | |
| 3173-72-6 | 1,5-Naphthalene diisocyanate | 3 | 19, Sup 7, 71 | 1999 | |
| 3252-43-5 | Dibromoacetonitrile | 2B | 52, 71, 101 | 2013 | |
| 3296-90-0 | 2,2-Bis(bromomethyl)propane-1,3-diol | 2B | 77 | 2000 | |
| 3351-28-8 | 1-Methylchrysene | 3 | Sup 7, 92 | 2010 | |
| 3351-30-2 | 4-Methylchrysene | 3 | Sup 7, 92 | 2010 | |
| 3351-31-3 | 3-Methylchrysene | 3 | Sup 7, 92 | 2010 | |
| 3351-32-4 | 2-Methylchrysene | 3 | Sup 7, 92 | 2010 | |
| 3564-09-8 | Ponceau 3R | 2B | 8, Sup 7 | 1987 | |
| 3567-69-9 | Carmoisine | 3 | 8, Sup 7 | 1987 | |
| 3570-75-0 | 2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole | 2B | 7, Sup 7 | 1987 | |
| 3688-53-7 | AF-2 [2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide] | 2B | 31, Sup 7 | 1987 | |
| 3697-24-3 | 5-Methylchrysene | 2B | Sup 7, 92 | 2010 | |
| 3761-53-3 | Ponceau MX | 2B | 8, Sup 7 | 1987 | |
| 3771-19-5 | Nafenopin | 2B | 24, Sup 7 | 1987 | |
| 3778-73-2 | Isophosphamide | 3 | 26, Sup 7 | 1987 | |
| 3795-88-8 | 5-(Morpholinomethyl)-3-[(5-nitrofurfurylidene)amino]-2-oxazolidinone | 2B | 7, Sup 7 | 1987 | |
| 3844-45-9 | Brilliant Blue FCF, disodium salt | 3 | 16, Sup 7 | 1987 | |
| 3902-71-4 | 4,5′,8-Trimethylpsoralen | 3 | 40, Sup 7 | 1987 | |
| 4063-41-6 | 4,5′-Dimethylangelicin plus ultraviolet A radiation | 3 | Sup 7 | 1987 | |
| 4170-30-3 | Crotonaldehyde | 3 | 63 | 1995 | |
| 4342-03-4 | Dacarbazine | 2B | 26, Sup 7 | 1987 | |
| 4548-53-2 | Ponceau SX | 3 | 8, Sup 7 | 1987 | |
| 4549-40-0 | N-Nitrosomethylvinylamine | 2B | 17, Sup 7 | 1987 | |
| 4657-93-6 | 5-Aminoacenaphthene | 3 | 16, Sup 7 | 1987 | |
| 4680-78-8 | Guinea Green B | 3 | 16, Sup 7 | 1987 | |
| 5131-60-2 | 4-Chloro-meta-phenylenediamine | 3 | 27, Sup 7 | 1987 | |
| 5141-20-8 | Light Green SF | 3 | 16, Sup 7 | 1987 | |
| 5160-02-1 | D & C Red No. 9 | 3 | Sup 7, 57 | 1993 | |
| 5307-14-2 | 1,4-Diamino-2-nitrobenzene | 3 | Sup 7, 57 | 1993 | |
| 5385-75-1 | Dibenzo[a,e]fluoranthene | 3 | Sup 7, 92 | 2010 | |
| 5431-33-4 | Glycidyl oleate | 3 | 11, Sup 7 | 1987 | |
| 5456-28-0 | Ethyl selenac | 3 | 12, Sup 7 | 1987 | |
| 5522-43-0 | 1-Nitropyrene | 2A | Sup 7, 46, 105 | 2014 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 5589-96-8 | Bromochloroacetic acid | 2B | 101 | 2013 | |
| 5989-27-5 | d-Limonene | 3 | 56, 73 | 1999 | NB: Overall evaluation downgraded to Group 3 with supporting evidence from other relevant data |
| 6164-98-3 | Chlordimeform | 3 | 30, Sup 7 | 1987 | |
| 6358-53-8 | Citrus Red No. 2 | 2B | 8, Sup 7 | 1987 | |
| 6368-72-5 | Sudan Red 7B | 3 | 8, Sup 7 | 1987 | |
| 6373-74-6 | CI Acid Orange 3 | 3 | 57 | 1993 | |
| 6416-57-5 | Sudan Brown RR | 3 | 8, Sup 7 | 1987 | |
| 6459-94-5 | CI Acid Red 114 | 2B | 57 | 1993 | |
| 6795-23-9 | Aflatoxin M1 | 2B | 56 | 1993 | |
| 6870-67-3 | Jacobine | 3 | 10, Sup 7 | 1987 | |
| 7099-43-6 | 5,6-Cyclopenteno-1,2-benzanthracene | 3 | 92 | 2010 | |
| 7220-79-3 | Methylene blue | 3 | 108 | In prep. | |
| 7439-92-1 | Lead | 2B | 23, Sup 7 | 1987 | |
| 7439-97-6 | Mercury and inorganic mercury compounds | 3 | 58 | 1993 | |
| 7440-02-0 | Nickel, metallic and alloys | 2B | Sup 7, 49 | 1990 | |
| 7440-07-5 | Plutonium | 1 | 78, 100D | 2012 | |
| 7440-29-1 | Thorium-232 and its decay products | 1 | 78, 100D | 2012 | |
| 7440-38-2 | Arsenic and inorganic arsenic compounds | 1 | 23, Sup 7, 100C | 2012 | |
| 7440-41-7 | Beryllium and beryllium compounds | 1 | Sup 7, 58, 100C | 2012 | |
| 7440-43-9 | Cadmium and cadmium compounds | 1 | 58, 100C | 2012 | |
| 7440-47-3 | Chromium, metallic | 3 | Sup 7, 49 | 1990 | |
| 7440-48-4 | Cobalt and cobalt compounds | 2B | 52 | 1991 | NB: Evaluated as a group |
| 7440-48-4 | Cobalt metal without tungsten carbide | 2B | 86 | 2006 | |
| 7440-48-4 12070-12-1 |
Cobalt metal with tungsten carbide | 2A | 86 | 2006 | |
| 7446-09-5 | Sulfur dioxide | 3 | 54 | 1992 | |
| 7460-84-6 | Glycidyl stearate | 3 | 11, Sup 7 | 1987 | |
| 7481-89-2 | Zalcitabine | 2B | 76 | 2000 | |
| 7496-02-8 | 6-Nitrochrysene | 2A | Sup 7, 46, 105 | 2014 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 7519-36-0 | N-Nitrosoproline | 3 | 17, Sup 7 | 1987 | |
| 7572-29-4 | Dichloroacetylene | 3 | 39, Sup 7, 71 | 1999 | |
| 7631-86-9 | Silica, amorphous | 3 | Sup 7, 68 | 1997 | |
| 7647-01-0 | Hydrochloric acid | 3 | 54 | 1992 | |
| 7664-93-9 | Strong-inorganic-acid mists containing sulfuric acid (see Acid mists) | ||||
| 7722-84-1 | Hydrogen peroxide | 3 | 36, Sup 7, 71 | 1999 | |
| 7758-01-2 | Potassium bromate | 2B | Sup 7, 73 | 1999 | |
| 7758-19-2 | Sodium chlorite | 3 | 52 | 1991 | |
| 7782-49-2 | Selenium and selenium compounds | 3 | 9, Sup 7 | 1987 | |
| 8001-35-2 | Toxaphene (Polychlorinated camphenes) | 2B | Sup 7, 79 | 2001 | |
| 8001-50-1 | Terpene polychlorinates (Strobane®) | 3 | 5, Sup 7 | 1987 | |
| 8001-58-9 | Creosotes | 2A | Sup 7, 92 | 2010 | |
| 8002-05-9 | Crude oil | 3 | 45 | 1989 | |
| 8007-45-2 | Coal tars (see Coal-tar distillation) | 35, Sup 7 | 1987 | ||
| 8007-45-2 | Coal-tar distillation | 1 | 92, 100F | 2012 | |
| 8018-07-3 | Acriflavinium chloride | 3 | 13, Sup 7 | 1987 | |
| 8047-67-4 | Saccharated iron oxide | 3 | 2, Sup 7 | 1987 | |
| 8052-42-4 | Bitumens, extracts of steam-refined and air-refined; steam-refined, cracking-residue and air-refined bitumens (see Bitumens, occupational exposures) | 35, Sup 7 | 1987 | ||
| 8052-42-4 64741-56-6 |
Bitumens, occupational exposure to straight-run bitumens and their emissions during road paving | 2B | 103 | 2013 | |
| 9000-07-1 | Carrageenan, native | 3 | 31, Sup 7 | 1987 | |
| 9000-38-8 | Kava extract | 2B | 108 | In prep. | |
| 9002-84-0 | Polytetrafluoroethylene | 3 | 19, Sup 7 | 1987 | |
| 9002-86-2 | Polyvinyl chloride | 3 | 19, Sup 7 | 1987 | |
| 9002-88-4 | Polyethylene | 3 | 19, Sup 7 | 1987 | |
| 9002-89-5 | Polyvinyl alcohol | 3 | 19, Sup 7 | 1987 | |
| 9003-01-4 | Polyacrylic acid | 3 | 19, Sup 7 | 1987 | |
| 9003-07-0 | Polypropylene | 3 | 19, Sup 7 | 1987 | |
| 9003-20-7 | Polyvinyl acetate | 3 | 19, Sup 7 | 1987 | |
| 9003-22-9 | Vinyl chloride-vinyl acetate copolymers | 3 | 19, Sup 7 | 1987 | |
| 9003-39-8 | Polyvinyl pyrrolidone | 3 | 19, Sup 7, 71 | 1987 | |
| 9003-53-6 | Polystyrene | 3 | 19, Sup 7 | 1987 | |
| 9003-54-7 | Styrene-acrylonitrile copolymers | 3 | 19, Sup .7 | 1987 | |
| 9003-55-8 | Styrene-butadiene copolymers | 3 | 19, Sup 7 | 1987 | |
| 9004-51-7 | Iron-dextrin complex | 3 | 2, Sup 7 | 1987 | |
| 9004-66-4 | Iron-dextran complex | 2B | 2, Sup 7 | 1987 | |
| 9009-54-5 | Polyurethane foams | 3 | 19, Sup 7 | 1987 | |
| 9010-98-4 | Polychloroprene | 3 | 19, Sup 7 | 1987 | |
| 9011-06-7 | Vinylidene chloride-vinyl chloride copolymers | 3 | 19, Sup 7 | 1987 | |
| 9011-14-7 | Polymethyl methacrylate | 3 | 19, Sup 7 | 1987 | |
| 9016-87-9 | Polymethylene polyphenyl isocyanate | 3 | 19, Sup 7 | 1987 | |
| 10026-24-1 | Cobalt sulfate and other soluble cobalt(II) salts | 2B | 86 | 2006 | |
| 10043-66-0 | Iodine-131 (see Radioiodines) | ||||
| 10043-92-2 | Radon-222 and its decay products | 1 | 43, 78, 100D | 2012 | |
| 10048-13-2 | Sterigmatocystin | 2B | 10, Sup 7 | 1987 | |
| 10048-32-5 | Parasorbic acid | 3 | 10, Sup 7 | 1987 | |
| 10098-97-2 | Strontium-90 (see Fission products) | ||||
| 10380-28-6 | Copper 8-hydroxyquinoline | 3 | 15, Sup 7 | 1987 | |
| 10540-29-1 | Tamoxifen | 1 | 66, 100A | 2012 | NB: There is also conclusive evidence that tamoxifen reduces the risk of contralateral breast cancer in breast cancer patients |
| 10595-95-6 | N-Nitrosomethylethylamine | 2B | 17, Sup 7 | 1987 | |
| 10599-90-3 | Chloramine | 3 | 84 | 2004 | |
| 11056-06-7 | Bleomycins | 2B | 26, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data |
| 12001-79-5 | Vitamin K substances | 3 | 76 | 2000 | |
| 12070-12-1 7440-48-4 |
Tungsten carbide with cobalt metal (see Cobalt metal with tungsten carbide) | ||||
| 12122-67-7 | Zineb | 3 | 12, Sup 7 | 1987 | |
| 12174-11-7 | Attapulgite (see Palygorskite) | ||||
| 12174-11-7 | Palygorskite (Attapulgite) (long fibres, > 5 micrometres) | 2B | 68 | 1997 | |
| 12174-11-7 | Palygorskite (Attapulgite)(short fibres, < 5 micrometres) | 3 | 68 | 1997 | |
| 12192-57-3 | Aurothioglucose | 3 | 13, Sup 7 | 1987 | |
| 12427-38-2 | Maneb | 3 | 12, Sup 7 | 1987 | |
| 12663-46-6 | Cyclochlorotine | 3 | 10, Sup 7 | 1987 | |
| 13010-47-4 | 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) | 2A | 26, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 13045-94-8 | Medphalan | 3 | 9, Sup 7 | 1987 | |
| 13233-32-4 | Radium-224 and its decay products | 1 | 78, 100D | 2012 | |
| 13256-22-9 | N-Nitrososarcosine | 2B | 17, Sup 7 | 1987 | |
| 13292-46-1 | Rifampicin | 3 | 24, Sup 7 | 1987 | |
| 13463-67-7 | Titanium dioxide | 2B | 47, 93 | 2010 | |
| 13483-18-6 | 1,2-Bis(chloromethoxy)ethane | 3 | 15; Sup 7, 71 | 1999 | |
| 13909-09-6 | 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) (see Semustine) | ||||
| 13909-09-6 | Semustine [1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, Methyl-CCNU] | 1 | Sup 7, 100A | 2012 | |
| 13982-63-3 | Radium-226 and its decay products | 1 | 78, 100D | 2012 | |
| 13983-17-0 | Wollastonite | 3 | Sup 7, 68 | 1997 | |
| 14484-64-1 | Ferbam | 3 | 12, Sup 7 | 1987 | |
| 14596-37-3 | Phosphorus-32, as phosphate | 1 | 78, 100D | 2012 | |
| 14807-96-6 | Talc containing asbestiform fibres (see Asbestos) | 42, Sup 7 | 1987 | ||
| 14807-96-6 | Talc not containing asbestos or asbestiform fibres | 3 | 42, Sup 7, 93 | 2010 | |
| 14807-96-6 | Talc-based body powder (perineal use of) | 2B | 93 | 2010 | |
| 14808-60-7 | Silica dust, crystalline, in the form of quartz or cristobalite | 1 | Sup 7, 68, 100C | 2012 | |
| 14901-08-7 | Cycasin | 2B | 10, Sup 7 | 1987 | |
| 15086-94-9 | Eosin | 3 | 15, Sup 7 | 1987 | |
| 15262-20-1 | Radium-228 and its decay products | 1 | 78, 100D | 2012 | |
| 15501-74-3 | Sepiolite | 3 | Sup 7, 68 | 1997 | |
| 15503-86-3 | Isatidine | 3 | 10, Sup 7 | 1987 | |
| 15663-27-1 | Cisplatin | 2A | 26, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 15721-02-5 | 2,2′,5,5′-Tetrachlorobenzidine | 3 | 27, Sup 7 | 1987 | |
| 16065-83-1 | Chromium (III) compounds | 3 | 49 | 1990 | |
| 16071-86-6 | CI Direct Brown 95 (see Benzidine, dyes metabolized to) | ||||
| 16543-55-8 64091-91-4 |
N‘-Nitrosonornicotine (NNN) and 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) | 1 | Sup 7, 89, 100E | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 16568-02-8 | Gyromitrin | 3 | 31, Sup 7 | 1987 | |
| 16984-48-8 | Fluorides (inorganic, used in drinking-water) | 3 | 27, Sup 7 | 1987 | |
| 17117-34-9 | 3-Nitrobenzanthrone | 2B | 105 | 2014 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 18540-29-9 | Chromium (VI) compounds | 1 | Sup 7, 49, 100C | 2012 | |
| 18883-66-4 | Streptozotocin | 2B | 17, Sup 7 | 1987 | |
| 20073-24-9 | 3-Carbethoxypsoralen | 3 | 40, Sup 7 | 1987 | |
| 20268-51-3 | 7-Nitrobenz[a]anthracene | 3 | 46 | 1989 | |
| 20589-63-3 | 3-Nitroperylene | 3 | 46 | 1989 | |
| 20830-75-5 | Digoxin | 2B | 108 | In prep. | |
| 20830-81-3 | Daunomycin | 2B | 10, Sup 7 | 1987 | |
| 20941-65-5 | Ethyl tellurac | 3 | 12, Sup 7 | 1987 | |
| 21884-44-6 | Luteoskyrin | 3 | 10, Sup 7 | 1987 | |
| 22248-79-9 | Tetrachlorvinphos | 2B | 30, Sup 7, 112 | In prep. | |
| 22349-59-3 | 1,4-Dimethylphenanthrene | 3 | Sup 7, 92 | 2010 | |
| 22398-80-7 | Indium phosphide | 2A | 86 | 2006 | NB: Overall evaluation upgraded to Group 2A |
| 22506-53-2 | 3,9-Dinitrofluoranthene | 2B | 46, 65, 105 | 2013 | |
| 22571-95-5 | Symphytine | 3 | 31, Sup 7 | 1987 | |
| 22966-79-6 | Oestradiol mustard | 3 | 9, Sup 7 | 1987 | |
| 22975-76-4 | 4,4′-Dimethylangelicin plus ultraviolet A radiation | 3 | Sup 7 | 1987 | |
| 23214-92-8 | Adriamycin | 2A | 10, Sup 7 | 1987 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 23246-96-0 | Riddelliine | 2B | 10, Sup 7, 82 | 2002 | |
| 23255-93-8 | Hycanthone mesylate | 3 | 13, Sup 7 | 1987 | |
| 23537-16-8 | Rugulosin | 3 | 40, Sup 7 | 1987 | |
| 23746-34-1 | Potassium bis(2-hydroxyethyl)dithiocarbamate | 3 | 12, Sup 7 | 1987 | |
| 24560-98-3 | cis-9,10-Epoxystearic acid | 3 | 11, Sup 7, 71 | 1999 | |
| 24938-64-5 | para-Aramid fibrils | 3 | 68 | 1997 | |
| 25013-15-4 | Vinyl toluene | 3 | 60 | 1994 | |
| 25013-16-5 | Butylated hydroxyanisole (BHA) | 2B | 40, Sup 7 | 1987 | |
| 25038-54-4 | Nylon 6 | 3 | 19, Sup 7 | 1987 | |
| 25732-74-5 | Acepyrene (3,4-dihydrocyclopenta[cd]pyrene) | 3 | 92 | 2010 | |
| 25812-30-0 | Gemfibrozil | 3 | 66 | 1996 | |
| 25962-77-0 | trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)-vinyl]-1,3,4-oxadiazole | 2B | 7, Sup 7 | 1987 | |
| 26148-68-5 | A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole) | 2B | 40, Sup 7 | 1987 | |
| 26308-28-1 | Ripazepam | 3 | 66 | 1996 | |
| 26471-62-5 | Toluene diisocyanates | 2B | 39, Sup 7, 71 | 1999 | |
| 26782-43-4 | Hydroxysenkirkine | 3 | 10, Sup 7 | 1987 | |
| 27208-37-3 | Cyclopenta[cd]pyrene | 2A | Sup 7, 92 | 2010 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 28434-86-8 | 3,3′-Dichloro-4,4′-diaminodiphenyl ether | 2B | 16, Sup 7 | 1987 | |
| 29069-24-7 | Prednimustine | 3 | 50 | 1990 | |
| 29291-35-8 | N-Nitrosofolic acid | 3 | 17, Sup 7 | 1987 | |
| 29767-20-2 | Teniposide | 2A | 76 | 2000 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 29975-16-4 | Estazolam | 3 | 66 | 1996 | |
| 30310-80-6 | N-Nitrosohydroxyproline | 3 | 17, Sup 7 | 1987 | |
| 30516-87-1 | Zidovudine (AZT) | 2B | 76 | 2000 | |
| 33229-34-4 | HC Blue No. 2 | 3 | 57 | 1993 | |
| 33419-42-0 | Etoposide | 1 | 76, 100A | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 33419-42-0 15663-27-1 11056-06-7 |
Etoposide in combination with cisplatin and bleomycin | 1 | 76, 100A | 2012 | |
| 33543-31-6 | 2-Methylfluoranthene | 3 | Sup 7, 92 | 2010 | |
| 37319-17-8 | Pentosan polysulfate sodium | 2B | 108 | In prep. | |
| 37620-20-5 | N‘-Nitrosoanabasine (NAB) | 3 | 37, Sup 7, 89 | 2007 | |
| 38571-73-2 | 1,2,3-Tris(chloromethoxy)propane | 3 | 15, Sup 7, 71 | 1999 | |
| 40762-15-0 | Doxefazepam | 3 | 66 | 1996 | |
| 42397-64-8 | 1,6-Dinitropyrene | 2B | 46, 105 | 2013 | |
| 42397-65-9 | 1,8-Dinitropyrene | 2B | Sup 7, 46, 105 | 2013 | |
| 51264-14-3 | Amsacrine | 2B | 76 | 2000 | |
| 51481-61-9 | Cimetidine | 3 | 50 | 1990 | |
| 51630-58-1 | Fenvalerate | 3 | 53 | 1991 | |
| 52645-53-1 | Permethrin | 3 | 53 | 1991 | |
| 52918-63-5 | Deltamethrin | 3 | 53 | 1991 | |
| 53973-98-1 | Carrageenan, degraded (Poligeenan) | 2B | 31, Sup 7 | 1987 | |
| 53973-98-1 | Poligeenan (see Carrageenan, degraded) | ||||
| 54749-90-5 | Chlorozotocin | 2A | 50 | 1990 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 55557-01-2 | N-Nitrosoguvacine | 3 | Sup 7, 85 | 2004 | |
| 55557-02-3 | N-Nitrosoguvacoline | 3 | Sup 7, 85 | 2004 | |
| 56894-91-8 | 1,4-Bis(chloromethoxymethyl)benzene | 3 | 15; Sup 7, 71 | 1999 | |
| 57018-52-7 | 1-tert-Butoxypropan-2-ol | 3 | 88 | 2006 | |
| 57117-31-4 | 2,3,4,7,8-Pentachlorodibenzofuran | 1 | 100F | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data |
| 57465-28-8 | 3,4,5,3’,4’-Pentachlorobiphenyl (PCB-126) | 1 | 100F | 2012 | See Polychlorinated biphenyls, dioxin-like, with a TEF according to WHO |
| 57835-92-4 | 4-Nitropyrene | 2B | 46, 105 | 2013 | |
| 59277-89-3 | Aciclovir | 3 | 76 | 2000 | |
| 59536-65-1 | Polybrominated biphenyls | 2A | 41, Sup 7, 107 | In prep. | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data, namely mechanistic similarity with polychlorinated biphenyls classified in Group 1 |
| 59820-43-8 | HC Yellow No. 4 | 3 | 57 | 1993 | |
| 59865-13-3 79217-60-0 |
Ciclosporin (see Cyclosporine) | ||||
| 59865-13-3 79217-60-0 |
Cyclosporine | 1 | 50, 100A | 2012 | |
| 60102-37-6 | Petasitenine | 3 | 31, Sup 7 | 1987 | |
| 60153-49-3 | 3-(N-Nitrosomethylamino)propionitrile | 2B | Sup 7, 85 | 2004 | |
| 62450-06-0 | Trp-P-1 (3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole) | 2B | 31, Sup 7 | 1987 | |
| 62450-07-1 | Trp-P-2 (3-Amino-1-methyl-5H-pyrido[4,3-b]indole) | 2B | 31, Sup 7 | 1987 | |
| 63041-90-7 | 6-Nitrobenzo[a]pyrene | 3 | Sup 7, 46 | 1989 | |
| 64436-13-1 | Arsenobetaine and other organic arsenic compounds that are not metabolized in humans | 3 | 100C | 2012 | |
| 64742-93-4 | Bitumens, occupational exposure to oxidized bitumens and their emissions during roofing | 2A | 103 | 2013 | |
| 65271-80-9 | Mitoxantrone | 2B | 76 | 2000 | |
| 65996-93-2 | Coal-tar pitch | 1 | 35, Sup 7, 100F | 2012 | |
| 66733-21-9 | Erionite | 1 | 42, Sup 7, 100C | 2012 | |
| 67730-10-3 | Glu-P-2 (2-Aminodipyrido[1,2-a:3′,2′-d]imidazole) | 2B | 40, Sup 7 | 1987 | |
| 67730-11-4 | Glu-P-1 (2-Amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole) | 2B | 40, Sup 7 | 1987 | |
| 68006-83-7 | MeA-alpha-C (2-Amino-3-methyl-9H-pyrido[2,3-b]indole) | 2B | 40, Sup 7 | 1987 | |
| 68308-34-9 | Shale oils | 1 | 35, Sup 7, 100F | 2012 | |
| 68603-42-9 | Coconut oil diethanolamine condensate | 2B | 101 | 2013 | |
| 69655-05-6 | Didanosine | 3 | 76 | 2000 | |
| 71267-22-6 | N‘-Nitrosoanatabine (NAT) | 3 | 37, Sup 7, 89 | 2007 | |
| 73459-03-7 | 5-Methylangelicin plus ultraviolet A radiation | 3 | Sup 7 | 1987 | |
| 75321-20-9 | 1,3-Dinitropyrene | 2B | 46, 105 | 2013 | |
| 76180-96-6 | IQ (2-Amino-3-methylimidazo[4,5-f]quinoline) | 2A | Sup 7, 56 | 1993 | NB: Overall evaluation upgraded to Group 2A with supporting evidence from other relevant data |
| 77094-11-2 | MeIQ (2-Amino-3,4-dimethylimidazo[4,5-f]quinoline) | 2B | Sup 7, 56 | 1993 | |
| 77439-76-0 | 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone | 2B | 84 | 2004 | |
| 77500-04-0 | MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) | 2B | Sup 7, 56 | 1993 | |
| 82413-20-5 | Droloxifene | 3 | 66 | 1996 | |
| 83463-62-1 | Bromochloroacetonitrile | 3 | 52, 71 | 1999 | |
| 85502-23-4 | 3-(N-Nitrosomethylamino)propionaldehyde | 3 | Sup 7, 85 | 2004 | |
| 85878-62-2 | Pyrido[3,4-c]psoralen | 3 | 40, Sup 7 | 1987 | |
| 85878-63-3 | 7-Methylpyrido[3,4-c]psoralen | 3 | 40, Sup 7 | 1987 | |
| 87625-62-5 | Ptaquiloside | 3 | 40, Sup 7 | 1987 | |
| 89778-26-7 | Toremifene | 3 | 66 | 1996 | |
| 90045-36-6 | Ginkgo biloba extract | 2B | 108 | In prep. | |
| 90370-29-9 | 4,4′,6-Trimethylangelicin plus ultraviolet A radiation | 3 | Sup 7 | 1987 | |
| 90456-67-0 [deleted] 924-42-5 |
N-Methylolacrylamide | 3 | 60 | 1994 | |
| 101043-37-2 | Microcystin-LR | 2B | 94 | 2010 | |
| 105650-23-5 | PhIP (2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) | 2B | 56 | 1993 | |
| 105735-71-5 | 3,7-Dinitrofluoranthene | 2B | 46, 65, 105 | 2013 | |
| 111025-46-8 | Pioglitazone | 2A | 108 | In prep. | |
| 111189-32-3 | Naphtho[1,2-b]fluoranthene | 3 | 92 | 2010 | |
| 116355-83-0 | Fumonisin B1 | 2B | 82 | 2002 | |
| 116355-83-0 | Fusarium moniliforme, toxins derived from (fumonisin B1, fumonisin B2, and fusarin C) | 2B | 56 | 1993 | |
| 118399-22-7 | Nodularins | 3 | 94 | 2010 | |
| 122320-73-4 | Rosiglitazone | 3 | 108 | In prep. | |
| 308068-56-6 | Carbon nanotubes, multi-walled MWCNT-7 | 2B | 111 | In prep. | |
| 308068-56-6 | Carbon nanotubes, multi-walled, other than MWCNT-7 | 3 | 111 | In prep. | |
| 308068-56-6 | Carbon nanotubes, single-walled | 3 | 111 | In prep. | |
| 308068-56-6 | Multi-walled carbon nanotubes MWCNT-7 (see Carbon nanotubes, multi-walled MWCNT-7) | ||||
| 308068-56-6 | Multi-walled carbon nanotubes other than MWCNT-7 (see Carbon nanotubes, multi-walled, other than MWCNT-7) | ||||
| 308068-56-6 | Single-walled carbon nanotubes (see Carbon nanotubes, single-walled) | ||||
| 308076-74-6 | Silicon carbide, fibrous | 2B | 111 | In prep. | |
| 409-21-2 | Silicon carbide whiskers | 2A | 111 | In prep. | |
| Acheson process, occupational exposure associated with | 1 | 111 | In prep. | ||
| Acid mists, strong inorganic | 1 | 54, 100F | 2012 | ||
| Acrylic fibres | 3 | 19, Sup 7 | 1987 | ||
| Acrylonitrile-butadiene-styrene copolymers | 3 | 19, Sup 7 | 1987 | ||
| Alcoholic beverages | 1 | 44, 96, 100E | 2012 | ||
| Aloe vera, whole leaf extract | 2B | 108 | In prep. | ||
| Alpha particles (see Radionuclides) | |||||
| Aluminium production | 1 | 34, Sup 7, 92, 100F | 2012 | ||
| Anaesthetics, volatile | 3 | 11, Sup 7 | 1987 | ||
| Androgenic (anabolic) steroids | 2A | Sup 7 | 1987 | ||
| Areca nut | 1 | 85, 100E | 2012 | ||
| Art glass, glass containers and pressed ware (manufacture of) | 2A | 58 | 1993 | ||
| Auramine production | 1 | Sup 7, 99, 100F | 2012 | ||
| Benzidine, dyes metabolized to | 1 | 99, 100F | 2012 | NB: Overall evaluation upgraded to Group 1 based on mechanistic and other relevant data | |
| Beta particles (see Radionuclides) | |||||
| Betel quid with tobacco | 1 | Sup 7, 85, 100E | 2012 | ||
| Betel quid without tobacco | 1 | Sup 7, 85, 100E | 2012 | ||
| Biomass fuel (primarily wood), indoor emissions from household combustion of | 2A | 95 | 2010 | ||
| Bisulfites | 3 | 54 | 1992 | ||
| Bitumens, occupational exposure to hard bitumens and their emissions during mastic asphalt work | 2B | 103 | 2013 | ||
| BK polyomavirus (BKV) | 2B | 104 | 2013 | ||
| Boot and shoe manufacture and repair (see Leather dust, Benzene) | 25, Sup 7 | 1987 | |||
| Bracken fern | 2B | 40, Sup 7 | 1987 | ||
| Calcium carbide production | 3 | 92 | 2010 | ||
| Carbon electrode manufacture | 2A | 92 | 2010 | ||
| Carpentry and joinery | 2B | 25, Sup 7 | 1987 | ||
| Chimney sweeping (see Soot) | 92 | 2010 | |||
| Chlorinated drinking-water | 3 | 52 | 1991 | ||
| Chlorinated paraffins of average carbon chain length C12 and average degree of chlorination approximately 60% | 2B | 48 | 1990 | ||
| Chlorophenols (see Polychlorophenols) | |||||
| Chlorophenoxy herbicides | 2B | 41, Sup 7 | 1987 | ||
| Clonorchis sinensis (infection with) | 1 | 61, 100B | 2012 | ||
| Coal dust | 3 | 68 | 1997 | ||
| Coal gasification | 1 | Sup 7, 92, 100F | 2012 | ||
| Coal, indoor emissions from household combustion of | 1 | 95, 100E | 2012 | ||
| Coffee (urinary bladder) | 2B | 51 | 1991 | NB: There is some evidence of an inverse relationship between coffee drinking and cancer of the large bowel; coffee drinking could not be classified as to its carcinogenicity to other organs | |
| Coke production | 1 | Sup 7, 92, 100F | 2012 | ||
| Continuous glass filament (see Glass filament) | |||||
| Diesel engine exhaust (see Engine exhaust, diesel) | |||||
| Diesel fuel, marine | 2B | 45 | 1989 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data | |
| Diesel fuels, distillate (light) | 3 | 45 | 1989 | ||
| Dry cleaning (occupational exposures in) | 2B | 63 | 1995 | ||
| Dyes metabolized to benzidine (see Benzidine, dyes metabolized to) | |||||
| Electric fields, extremely low-frequency | 3 | 80 | 2002 | ||
| Electric fields, static | 3 | 80 | 2002 | ||
| Engine exhaust, diesel | 1 | 46, 105 | 2013 | ||
| Engine exhaust, gasoline | 2B | 46, 105 | 2013 | ||
| Epstein-Barr virus | 1 | 70, 100B | 2012 | ||
| Estrogen therapy, postmenopausal | 1 | 72, 100A | 2012 | ||
| Estrogen-progestogen menopausal therapy (combined) | 1 | 72, 91, 100A | 2012 | ||
| Estrogen-progestogen oral contraceptives (combined) | 1 | 72, 91, 100A | 2012 | NB: There is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary | |
| Firefighter (occupational exposure as a) | 2B | 98 | 2010 | ||
| Fission products, including strontium-90 | 1 | 100D | 2012 | ||
| Flat-glass and specialty glass (manufacture of) | 3 | 58 | 1993 | ||
| Fluorescent lighting | 3 | 55 | 1992 | ||
| Fluoro-edenite fibrous amphibole | 1 | 111 | In prep. | ||
| Foreign bodies (see Surgical implants and other foreign bodies) | |||||
| Frying, emissions from high-temperature | 2A | 95 | 2010 | ||
| Fuel oils, distillate (light) | 3 | 45 | 1989 | ||
| Fuel oils, residual (heavy) | 2B | 45 | 1989 | ||
| Furniture and cabinet making (see Wood dust) | 25, Sup 7 | 1987 | |||
| Fusarium graminearum, F. culmorum, and F. crookwellense, toxins derived from (zearalenone, deoxynivalenol, nivalenol, and fusarenone X) | 3 | Sup 7, 56 | 1993 | ||
| Fusarium sporotrichioides, toxins derived from (T-2 toxin) | 3 | 56 | 1993 | ||
| Gamma-Radiation (see X- and Gamma-Radiation) | |||||
| Gasoline | 2B | 45 | 1989 | NB: Overall evaluation upgraded to Group 2B with supporting evidence from other relevant data | |
| Gasoline engine exhaust (see Engine exhaust, gasoline) | |||||
| Glass filament, continuous | 3 | 43, 81 | 2002 | ||
| Goldenseal root powder | 2B | 108 | In prep. | ||
| Haematite mining (underground) | 1 | 1, Sup 7, 100D | 2012 | ||
| Hair colouring products (personal use of) | 3 | 57, 99 | 2010 | ||
| Hairdresser or barber (occupational exposure as a) | 2A | 57, 99 | 2010 | ||
| Helicobacter pylori (infection with) | 1 | 61, 100B | 2012 | ||
| Hepatitis B virus (chronic infection with) | 1 | 59, 100B | 2012 | ||
| Hepatitis C virus (chronic infection with) | 1 | 59, 100B | 2012 | ||
| Hepatitis D virus | 3 | 59 | 1994 | ||
| Hexachlorocyclohexanes | 2B | 20, Sup 7 | 1987 | ||
| High-temperature frying (see Frying) | |||||
| Hot mate (see Mate, hot) | |||||
| Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of) | |||||
| Household combustion of coal (see Coal, indoor emissions from household combustion) | |||||
| Human herpesvirus type 4 (see Epstein-Barr virus) | |||||
| Human herpesvirus type 8 (see Kaposi sarcoma herpesvirus) | |||||
| Human immunodeficiency virus type 1 (infection with) | 1 | 67, 100B | 2012 | ||
| Human immunodeficiency virus type 2 (infection with) | 2B | 67 | 1996 | ||
| Human papillomavirus genus beta (except types 5 and 8) and genus gamma | 3 | 90, 100B | 2012 | ||
| Human papillomavirus type 68 | 2A | 100B | 2012 | ||
| Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 | 1 | 64, 90, 100B | 2012 | NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer | |
| Human papillomavirus types 26, 53, 66, 67, 70, 73, 82 | 2B | 100B | 2012 | ||
| Human papillomavirus types 30, 34, 69, 85, 97 | 2B | 100B | 2012 | NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1 | |
| Human papillomavirus types 5 and 8 (in patients with epidermodysplasia verruciformis) | 2B | 100B | 2012 | ||
| Human papillomavirus types 6 and 11 | 3 | 90, 100B | 2012 | ||
| Human T-cell lymphotropic virus type I | 1 | 67, 100B | 2012 | ||
| Human T-cell lymphotropic virus type II | 3 | 67 | 1996 | ||
| Hypochlorite salts | 3 | 52 | 1991 | ||
| Insulation glass wool | 3 | 43, 81 | 2002 | ||
| Involuntary smoking (see Tobacco smoke, second-hand) | |||||
| Ionizing radiation (all types) | 1 | 100D | 2012 | ||
| Iron and steel founding (occupational exposure during) | 1 | 34, Sup 7, 100F | 2012 | ||
| Isopropyl alcohol manufacture using strong acids | 1 | Sup 7, 100F | 2012 | ||
| Isopropyl oils | 3 | 15, Sup 7, 71 | 1999 | ||
| JC polyomavirus (JCV) | 2B | 104 | 2013 | ||
| Jet fuel | 3 | 45 | 1989 | ||
| Kaposi sarcoma herpesvirus | 1 | 70, 100B | 2012 | ||
| Lead compounds, inorganic | 2A | Sup 7, 87 | 2006 | ||
| Lead compounds, organic | 3 | 23, Sup 7, 87 | 2006 | NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead | |
| Leather dust | 1 | 100C | 2012 | ||
| Leather goods manufacture | 3 | 25, Sup 7 | 1987 | ||
| Leather tanning and processing | 3 | 25, Sup 7 | 1987 | ||
| Lumber and sawmill industries (including logging) | 3 | 25, Sup 7 | 1987 | ||
| Madder root (Rubia tinctorum) | 3 | 82 | 2002 | ||
| Magenta production | 1 | Sup 7, 57, 99, 100F | 2012 | ||
| Magnetic fields, extremely low-frequency | 2B | 80 | 2002 | ||
| Magnetic fields, static | 3 | 80 | 2002 | ||
| Malaria (caused by infection with Plasmodium falciparum in holoendemic areas) | 2A | 104 | 2013 | ||
| Mate | 3 | 51 | 1991 | ||
| Mate, hot | 2A | 51 | 1991 | ||
| Merkel cell polyomavirus (MCV) | 2A | 104 | 2013 | ||
| Metabisulfites | 3 | 54 | 1992 | ||
| Methylmercury compounds | 2B | 58 | 1993 | NB: Evaluated as a group | |
| Microcystis extracts | 3 | 94 | 2010 | ||
| Mineral oils, highly-refined | 3 | 33, Sup 7 | 1987 | ||
| Mineral oils, untreated or mildly treated | 1 | 33, Sup 7, 100F | 2012 | ||
| Modacrylic fibres | 3 | 19, Sup 7 | 1987 | ||
| MOPP and other combined chemotherapy including alkylating agents | 1 | Sup 7, 100A | 2012 | ||
| Neutron radiation | 1 | 75, 100D | 2012 | NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data | |
| Nickel compounds | 1 | Sup 7, 49, 100C | 2012 | ||
| Nickel refining (see Nickel compounds) | 11 | 1976 | |||
| Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation | 2A | 94 | 2010 | ||
| Non-arsenical insecticides (occupational exposures in spraying and application of) | 2A | 53 | 1991 | ||
| Oestrogen (see Estrogen) | |||||
| Opisthorchis felineus (infection with) | 3 | 61 | 1994 | ||
| Opisthorchis viverrini (infection with) | 1 | 61, 100B | 2012 | ||
| Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives) | |||||
| Outdoor air pollution | 1 | 109 | In prep. | ||
| Outdoor air pollution, particulate matter in | 1 | 109 | In prep. | ||
| Paint manufacture (occupational exposure in) | 3 | 47 | 1989 | ||
| Painter (occupational exposure as a) | 1 | 47, 98, 100F | 2012 | ||
| Particulate matter in outdoor air pollution (see Outdoor air pollution, particulate matter in) | |||||
| Paving and roofing with coal-tar pitch (see Coal-tar pitch) | 35, Sup 7, 92, 100F | 2010 | |||
| Petroleum refining (occupational exposures in) | 2A | 45 | 1989 | ||
| Petroleum solvents | 3 | 47 | 1989 | ||
| Phenacetin, analgesic mixtures containing | 1 | Sup 7, 100A | 2012 | ||
| Pickled vegetables (traditional Asian) | 2B | 56 | 1993 | ||
| Polychlorinated biphenyls, dioxin-like, with a Toxicity Equivalency Factor (TEF) according to WHO (PCBs 77, 81, 105, 114, 118, 123, 126, 156, 157, 167, 169, 189) | 1 | 107 | In prep. | NB: Overall evaluation upgraded to Group 1 with strong supporting evidence from other relevant data | |
| Polychlorinated dibenzofurans (see 2,3,4,7,8-Pentachlorodibenzofuran) | 3 | 69 | 1997 | ||
| Polychlorinated dibenzo-para-dioxins (other than 2,3,7,8-tetrachlorodibenzo-para-dioxin) | 3 | 69 | 1997 | ||
| Polychlorophenols and their sodium salts (mixed exposures) | 2B | 53, 71 | 1999 | ||
| Printing inks | 3 | 65 | 1996 | ||
| Printing processes (occupational exposures in) | 2B | 65 | 1996 | ||
| Processed meat (consumption of) | 1 | 114 | In prep. | ||
| Proflavine salts | 3 | 24, Sup 7 | 1987 | ||
| Progestins | 2B | Sup 7 | 1987 | ||
| Progestogen-only contraceptives | 2B | 72 | 1999 | ||
| Pulp and paper manufacture | 3 | 25, Sup 7 | 1987 | ||
| Radiofrequency electromagnetic fields | 2B | 102 | 2013 | ||
| Radioiodines, including iodine-131 | 1 | 78, 100D | 2012 | ||
| Radionuclides, alpha-particle-emitting, internally deposited | 1 | 78, 100D | 2012 | NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents | |
| Radionuclides, beta-particle-emitting, internally deposited | 1 | 78, 100D | 2012 | NB: Specific radionuclides for which there is sufficient evidence in humans are also listed individually as Group 1 agents | |
| Red Meat (consumption of) | 2A | 114 | In prep. | ||
| Refractory ceramic fibres | 2B | 43, 81 | 2002 | ||
| Rock (stone) wool | 3 | 43, 81 | 2002 | ||
| Rubber manufacturing industry | 1 | 28, Sup 7, 100F | 2012 | ||
| Salted fish, Chinese-style | 1 | 56, 100E | 2012 | ||
| Schistosoma haematobium (infection with) | 1 | 61, 100B | 2012 | ||
| Schistosoma japonicum (infection with) | 2B | 61 | 1994 | ||
| Schistosoma mansoni (infection with) | 3 | 61 | 1994 | ||
| Shiftwork that involves circadian disruption | 2A | 98 | 2010 | ||
| Slag wool | 3 | 43, 81 | 2002 | ||
| Solar radiation | 1 | 55, 100D | 2012 | ||
| Soot (as found in occupational exposure of chimney sweeps) | 1 | 35, Sup 7, 92, 100F | 2012 | ||
| Special-purpose fibres such as E-glass and ‘475’ glass fibres | 2B | 81 | 2002 | ||
| Sulfites | 3 | 54 | 1992 | ||
| Sunlamps and sunbeds (see Ultraviolet-emitting tanning devices) | |||||
| Surgical implants and other foreign bodies: – Organic polymeric materials (as a group) – Orthopaedic implants of complex composition – Cardiac pacemakers – Silicone breast implants – Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based and titanium-based alloys, stainless steel and depleted uranium – Dental materials – Ceramic implants | 3 | 74 | 1999 | ||
| Surgical implants and other foreign bodies: – Polymeric implants prepared as thin smooth film (with the exception of poly(glycolic acid)) – Metallic implants prepared as thin smooth films – Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium and 7% iron | 2B | 74 | 1999 | ||
| SV40 polyomavirus | 3 | 104 | 2013 | ||
| Tea | 3 | 51 | 1991 | ||
| Tetrakis(hydroxymethyl)phosphonium salts | 3 | 48, 71 | 1999 | ||
| Textile manufacturing industry (work in) | 2B | 48 | 1990 | ||
| Tobacco smoke, second-hand | 1 | 83, 100E | 2012 | ||
| Tobacco smoking | 1 | 83, 100E | 2012 | ||
| Tobacco, smokeless | 1 | Sup 7, 89, 100E | 2012 | ||
| Toxins derived from certain Fusarium species (see Fusarium) | |||||
| Ultraviolet radiation (wavelengths 100-400 nm, encompassing UVA, UVB, and UVC) | 1 | 55, 100D | 2012 | ||
| Ultraviolet-emitting tanning devices | 1 | 100D | 2012 | ||
| Urethane (see Ethyl carbamate) | |||||
| Welding fumes | 2B | 49 | 1990 | NB: Volume 100D concluded that there is sufficient evidence for ocular melanoma in welders | |
| Wood dust | 1 | 62, 100C | 2012 | ||
| Wood smoke (see Biomass fuel, indoor emissions from household combustion) | |||||
| X- and Gamma-Radiation | 1 | 75, 100D | 2012 |
